id	sid	tid	token	lemma	pos
cord-274307-kl0uvrbw	1	1	key	key	NN
cord-274307-kl0uvrbw	1	2	:	:	:
cord-274307-kl0uvrbw	2	1	cord-274307-kl0uvrbw	cord-274307-kl0uvrbw	.
cord-274307-kl0uvrbw	3	1	authors	author	NNS
cord-274307-kl0uvrbw	3	2	:	:	:
cord-274307-kl0uvrbw	3	3	Bordet	Bordet	NNP
cord-274307-kl0uvrbw	3	4	,	,	,
cord-274307-kl0uvrbw	3	5	Régis	Régis	NNP
cord-274307-kl0uvrbw	3	6	title	title	NN
cord-274307-kl0uvrbw	3	7	:	:	:
cord-274307-kl0uvrbw	3	8	Is	be	VBZ
cord-274307-kl0uvrbw	3	9	the	the	DT
cord-274307-kl0uvrbw	3	10	drug	drug	NN
cord-274307-kl0uvrbw	3	11	a	a	DT
cord-274307-kl0uvrbw	3	12	scientific	scientific	JJ
cord-274307-kl0uvrbw	3	13	,	,	,
cord-274307-kl0uvrbw	3	14	social	social	JJ
cord-274307-kl0uvrbw	3	15	or	or	CC
cord-274307-kl0uvrbw	3	16	political	political	JJ
cord-274307-kl0uvrbw	3	17	object	object	NN
cord-274307-kl0uvrbw	3	18	?	?	.
cord-274307-kl0uvrbw	4	1	date	date	NN
cord-274307-kl0uvrbw	4	2	:	:	:
cord-274307-kl0uvrbw	4	3	2020	2020	CD
cord-274307-kl0uvrbw	4	4	-	-	HYPH
cord-274307-kl0uvrbw	4	5	05	05	CD
cord-274307-kl0uvrbw	4	6	-	-	HYPH
cord-274307-kl0uvrbw	4	7	23	23	CD
cord-274307-kl0uvrbw	4	8	journal	journal	NN
cord-274307-kl0uvrbw	4	9	:	:	:
cord-274307-kl0uvrbw	5	1	Therapie	Therapie	NNP
cord-274307-kl0uvrbw	5	2	DOI	DOI	NNP
cord-274307-kl0uvrbw	5	3	:	:	:
cord-274307-kl0uvrbw	5	4	10.1016	10.1016	CD
cord-274307-kl0uvrbw	5	5	/	/	SYM
cord-274307-kl0uvrbw	5	6	j.therap.2020.05.012	j.therap.2020.05.012	NN
cord-274307-kl0uvrbw	5	7	sha	sha	XX
cord-274307-kl0uvrbw	5	8	:	:	:
cord-274307-kl0uvrbw	6	1	9f7d116964173a2c157a45c9bcc31d82f11f2692	9f7d116964173a2c157a45c9bcc31d82f11f2692	CD
cord-274307-kl0uvrbw	6	2	doc_id	doc_id	CD
cord-274307-kl0uvrbw	6	3	:	:	:
cord-274307-kl0uvrbw	7	1	274307	274307	CD
cord-274307-kl0uvrbw	7	2	cord_uid	cord_uid	NNS
cord-274307-kl0uvrbw	7	3	:	:	:
cord-274307-kl0uvrbw	7	4	kl0uvrbw	kl0uvrbw	.
cord-274307-kl0uvrbw	8	1	nan	nan	NNP
cord-274307-kl0uvrbw	8	2	Randomized	Randomized	NNP
cord-274307-kl0uvrbw	8	3	controlled	control	VBN
cord-274307-kl0uvrbw	8	4	trials	trial	NNS
cord-274307-kl0uvrbw	8	5	are	be	VBP
cord-274307-kl0uvrbw	8	6	based	base	VBN
cord-274307-kl0uvrbw	8	7	on	on	IN
cord-274307-kl0uvrbw	8	8	two	two	CD
cord-274307-kl0uvrbw	8	9	principles	principle	NNS
cord-274307-kl0uvrbw	8	10	:	:	:
cord-274307-kl0uvrbw	8	11	comparison	comparison	NN
cord-274307-kl0uvrbw	8	12	and	and	CC
cord-274307-kl0uvrbw	8	13	comparability	comparability	NN
cord-274307-kl0uvrbw	8	14	.	.	.
cord-274307-kl0uvrbw	9	1	These	these	DT
cord-274307-kl0uvrbw	9	2	two	two	CD
cord-274307-kl0uvrbw	9	3	principles	principle	NNS
cord-274307-kl0uvrbw	9	4	allow	allow	VBP
cord-274307-kl0uvrbw	9	5	dispensing	dispense	VBG
cord-274307-kl0uvrbw	9	6	first	first	RB
cord-274307-kl0uvrbw	9	7	with	with	IN
cord-274307-kl0uvrbw	9	8	the	the	DT
cord-274307-kl0uvrbw	9	9	natural	natural	JJ
cord-274307-kl0uvrbw	9	10	evolution	evolution	NN
cord-274307-kl0uvrbw	9	11	of	of	IN
cord-274307-kl0uvrbw	9	12	the	the	DT
cord-274307-kl0uvrbw	9	13	disease	disease	NN
cord-274307-kl0uvrbw	9	14	,	,	,
cord-274307-kl0uvrbw	9	15	particularly	particularly	RB
cord-274307-kl0uvrbw	9	16	in	in	IN
cord-274307-kl0uvrbw	9	17	infectious	infectious	JJ
cord-274307-kl0uvrbw	9	18	diseases	disease	NNS
cord-274307-kl0uvrbw	9	19	,	,	,
cord-274307-kl0uvrbw	9	20	and	and	CC
cord-274307-kl0uvrbw	9	21	second	second	RB
cord-274307-kl0uvrbw	9	22	the	the	DT
cord-274307-kl0uvrbw	9	23	placebo	placebo	NN
cord-274307-kl0uvrbw	9	24	effect	effect	NN
cord-274307-kl0uvrbw	9	25	,	,	,
cord-274307-kl0uvrbw	9	26	which	which	WDT
cord-274307-kl0uvrbw	9	27	can	can	MD
cord-274307-kl0uvrbw	9	28	now	now	RB
cord-274307-kl0uvrbw	9	29	be	be	VB
cord-274307-kl0uvrbw	9	30	corroborated	corroborate	VBN
cord-274307-kl0uvrbw	9	31	by	by	IN
cord-274307-kl0uvrbw	9	32	brain	brain	NN
cord-274307-kl0uvrbw	9	33	imaging	imaging	NN
cord-274307-kl0uvrbw	9	34	studies	study	NNS
cord-274307-kl0uvrbw	9	35	.	.	.
cord-274307-kl0uvrbw	10	1	Without	without	IN
cord-274307-kl0uvrbw	10	2	respect	respect	NN
cord-274307-kl0uvrbw	10	3	for	for	IN
cord-274307-kl0uvrbw	10	4	these	these	DT
cord-274307-kl0uvrbw	10	5	two	two	CD
cord-274307-kl0uvrbw	10	6	principles	principle	NNS
cord-274307-kl0uvrbw	10	7	,	,	,
cord-274307-kl0uvrbw	10	8	it	-PRON-	PRP
cord-274307-kl0uvrbw	10	9	is	be	VBZ
cord-274307-kl0uvrbw	10	10	impossible	impossible	JJ
cord-274307-kl0uvrbw	10	11	to	to	TO
cord-274307-kl0uvrbw	10	12	establish	establish	VB
cord-274307-kl0uvrbw	10	13	the	the	DT
cord-274307-kl0uvrbw	10	14	role	role	NN
cord-274307-kl0uvrbw	10	15	of	of	IN
cord-274307-kl0uvrbw	10	16	the	the	DT
cord-274307-kl0uvrbw	10	17	drug	drug	NN
cord-274307-kl0uvrbw	10	18	in	in	IN
cord-274307-kl0uvrbw	10	19	the	the	DT
cord-274307-kl0uvrbw	10	20	clinical	clinical	JJ
cord-274307-kl0uvrbw	10	21	effects	effect	NNS
cord-274307-kl0uvrbw	10	22	observed	observe	VBD
cord-274307-kl0uvrbw	10	23	when	when	WRB
cord-274307-kl0uvrbw	10	24	testing	test	VBG
cord-274307-kl0uvrbw	10	25	a	a	DT
cord-274307-kl0uvrbw	10	26	new	new	JJ
cord-274307-kl0uvrbw	10	27	pharmacological	pharmacological	JJ
cord-274307-kl0uvrbw	10	28	approach	approach	NN
cord-274307-kl0uvrbw	10	29	.	.	.
cord-274307-kl0uvrbw	11	1	Paradoxically	paradoxically	RB
cord-274307-kl0uvrbw	11	2	,	,	,
cord-274307-kl0uvrbw	11	3	the	the	DT
cord-274307-kl0uvrbw	11	4	methodological	methodological	JJ
cord-274307-kl0uvrbw	11	5	rigour	rigour	NN
cord-274307-kl0uvrbw	11	6	inherent	inherent	JJ
cord-274307-kl0uvrbw	11	7	to	to	IN
cord-274307-kl0uvrbw	11	8	controlled	control	VBN
cord-274307-kl0uvrbw	11	9	trials	trial	NNS
cord-274307-kl0uvrbw	11	10	and	and	CC
cord-274307-kl0uvrbw	11	11	the	the	DT
cord-274307-kl0uvrbw	11	12	role	role	NN
cord-274307-kl0uvrbw	11	13	of	of	IN
cord-274307-kl0uvrbw	11	14	the	the	DT
cord-274307-kl0uvrbw	11	15	pharmaceutical	pharmaceutical	JJ
cord-274307-kl0uvrbw	11	16	industry	industry	NN
cord-274307-kl0uvrbw	11	17	in	in	IN
cord-274307-kl0uvrbw	11	18	promoting	promote	VBG
cord-274307-kl0uvrbw	11	19	these	these	DT
cord-274307-kl0uvrbw	11	20	trials	trial	NNS
cord-274307-kl0uvrbw	11	21	have	have	VBP
cord-274307-kl0uvrbw	11	22	ended	end	VBN
cord-274307-kl0uvrbw	11	23	up	up	RP
cord-274307-kl0uvrbw	11	24	bringing	bring	VBG
cord-274307-kl0uvrbw	11	25	discredit	discredit	NN
cord-274307-kl0uvrbw	11	26	to	to	IN
cord-274307-kl0uvrbw	11	27	this	this	DT
cord-274307-kl0uvrbw	11	28	approach	approach	NN
cord-274307-kl0uvrbw	11	29	,	,	,
cord-274307-kl0uvrbw	11	30	which	which	WDT
cord-274307-kl0uvrbw	11	31	is	be	VBZ
cord-274307-kl0uvrbw	11	32	,	,	,
cord-274307-kl0uvrbw	11	33	however	however	RB
cord-274307-kl0uvrbw	11	34	,	,	,
cord-274307-kl0uvrbw	11	35	the	the	DT
cord-274307-kl0uvrbw	11	36	best	good	JJS
cord-274307-kl0uvrbw	11	37	method	method	NN
cord-274307-kl0uvrbw	11	38	for	for	IN
cord-274307-kl0uvrbw	11	39	establishing	establish	VBG
cord-274307-kl0uvrbw	11	40	the	the	DT
cord-274307-kl0uvrbw	11	41	proven	prove	VBN
cord-274307-kl0uvrbw	11	42	effect	effect	NN
cord-274307-kl0uvrbw	11	43	of	of	IN
cord-274307-kl0uvrbw	11	44	a	a	DT
cord-274307-kl0uvrbw	11	45	drug	drug	NN
cord-274307-kl0uvrbw	11	46	,	,	,
cord-274307-kl0uvrbw	11	47	in	in	IN
cord-274307-kl0uvrbw	11	48	part	part	NN
cord-274307-kl0uvrbw	11	49	of	of	IN
cord-274307-kl0uvrbw	11	50	the	the	DT
cord-274307-kl0uvrbw	11	51	population	population	NN
cord-274307-kl0uvrbw	11	52	.	.	.
cord-274307-kl0uvrbw	12	1	The	the	DT
cord-274307-kl0uvrbw	12	2	craze	craze	NN
cord-274307-kl0uvrbw	12	3	that	that	WDT
cord-274307-kl0uvrbw	12	4	has	have	VBZ
cord-274307-kl0uvrbw	12	5	arisen	arise	VBN
cord-274307-kl0uvrbw	12	6	for	for	IN
cord-274307-kl0uvrbw	12	7	the	the	DT
cord-274307-kl0uvrbw	12	8	distribution	distribution	NN
cord-274307-kl0uvrbw	12	9	of	of	IN
cord-274307-kl0uvrbw	12	10	hydroxychloroquine	hydroxychloroquine	NN
cord-274307-kl0uvrbw	12	11	,	,	,
cord-274307-kl0uvrbw	12	12	based	base	VBN
cord-274307-kl0uvrbw	12	13	on	on	IN
cord-274307-kl0uvrbw	12	14	a	a	DT
cord-274307-kl0uvrbw	12	15	very	very	RB
cord-274307-kl0uvrbw	12	16	preliminary	preliminary	JJ
cord-274307-kl0uvrbw	12	17	study	study	NN
cord-274307-kl0uvrbw	12	18	and	and	CC
cord-274307-kl0uvrbw	12	19	the	the	DT
cord-274307-kl0uvrbw	12	20	analysis	analysis	NN
cord-274307-kl0uvrbw	12	21	of	of	IN
cord-274307-kl0uvrbw	12	22	a	a	DT
cord-274307-kl0uvrbw	12	23	cohort	cohort	NN
cord-274307-kl0uvrbw	12	24	without	without	IN
cord-274307-kl0uvrbw	12	25	a	a	DT
cord-274307-kl0uvrbw	12	26	comparator	comparator	NN
cord-274307-kl0uvrbw	12	27	group	group	NN
cord-274307-kl0uvrbw	12	28	,	,	,
cord-274307-kl0uvrbw	12	29	was	be	VBD
cord-274307-kl0uvrbw	12	30	,	,	,
cord-274307-kl0uvrbw	12	31	from	from	IN
cord-274307-kl0uvrbw	12	32	this	this	DT
cord-274307-kl0uvrbw	12	33	point	point	NN
cord-274307-kl0uvrbw	12	34	of	of	IN
cord-274307-kl0uvrbw	12	35	view	view	NN
cord-274307-kl0uvrbw	12	36	,	,	,
cord-274307-kl0uvrbw	12	37	very	very	RB
cord-274307-kl0uvrbw	12	38	emblematic	emblematic	JJ
cord-274307-kl0uvrbw	12	39	of	of	IN
cord-274307-kl0uvrbw	12	40	the	the	DT
cord-274307-kl0uvrbw	12	41	fact	fact	NN
cord-274307-kl0uvrbw	12	42	that	that	IN
cord-274307-kl0uvrbw	12	43	belief	belief	NN
cord-274307-kl0uvrbw	12	44	can	can	MD
cord-274307-kl0uvrbw	12	45	quickly	quickly	RB
cord-274307-kl0uvrbw	12	46	replace	replace	VB
cord-274307-kl0uvrbw	12	47	scientific	scientific	JJ
cord-274307-kl0uvrbw	12	48	demonstration	demonstration	NN
cord-274307-kl0uvrbw	12	49	.	.	.
cord-274307-kl0uvrbw	13	1	This	this	DT
cord-274307-kl0uvrbw	13	2	is	be	VBZ
cord-274307-kl0uvrbw	13	3	not	not	RB
cord-274307-kl0uvrbw	13	4	new	new	JJ
cord-274307-kl0uvrbw	13	5	and	and	CC
cord-274307-kl0uvrbw	13	6	already	already	RB
cord-274307-kl0uvrbw	13	7	exists	exist	VBZ
cord-274307-kl0uvrbw	13	8	for	for	IN
cord-274307-kl0uvrbw	13	9	alternative	alternative	JJ
cord-274307-kl0uvrbw	13	10	therapeutic	therapeutic	JJ
cord-274307-kl0uvrbw	13	11	methods	method	NNS
cord-274307-kl0uvrbw	13	12	that	that	WDT
cord-274307-kl0uvrbw	13	13	refuse	refuse	VBP
cord-274307-kl0uvrbw	13	14	to	to	TO
cord-274307-kl0uvrbw	13	15	fall	fall	VB
cord-274307-kl0uvrbw	13	16	under	under	IN
cord-274307-kl0uvrbw	13	17	the	the	DT
cord-274307-kl0uvrbw	13	18	caudine	caudine	NN
cord-274307-kl0uvrbw	13	19	forks	fork	NNS
cord-274307-kl0uvrbw	13	20	(	(	-LRB-
cord-274307-kl0uvrbw	13	21	so	so	RB
cord-274307-kl0uvrbw	13	22	named	name	VBN
cord-274307-kl0uvrbw	13	23	in	in	IN
cord-274307-kl0uvrbw	13	24	reference	reference	NN
cord-274307-kl0uvrbw	13	25	to	to	IN
cord-274307-kl0uvrbw	13	26	the	the	DT
cord-274307-kl0uvrbw	13	27	battle	battle	NN
cord-274307-kl0uvrbw	13	28	at	at	IN
cord-274307-kl0uvrbw	13	29	the	the	DT
cord-274307-kl0uvrbw	13	30	end	end	NN
cord-274307-kl0uvrbw	13	31	of	of	IN
cord-274307-kl0uvrbw	13	32	which	which	WDT
cord-274307-kl0uvrbw	13	33	the	the	DT
cord-274307-kl0uvrbw	13	34	romans	romans	NNPS
cord-274307-kl0uvrbw	13	35	had	have	VBD
cord-274307-kl0uvrbw	13	36	to	to	TO
cord-274307-kl0uvrbw	13	37	submit	submit	VB
cord-274307-kl0uvrbw	13	38	to	to	IN
cord-274307-kl0uvrbw	13	39	the	the	DT
cord-274307-kl0uvrbw	13	40	samnites	samnite	NNS
cord-274307-kl0uvrbw	13	41	)	)	-RRB-
cord-274307-kl0uvrbw	13	42	of	of	IN
cord-274307-kl0uvrbw	13	43	clinical	clinical	JJ
cord-274307-kl0uvrbw	13	44	trial	trial	NN
cord-274307-kl0uvrbw	13	45	methodology	methodology	NN
cord-274307-kl0uvrbw	13	46	.	.	.
cord-274307-kl0uvrbw	14	1	This	this	DT
cord-274307-kl0uvrbw	14	2	attitude	attitude	NN
cord-274307-kl0uvrbw	14	3	has	have	VBZ
cord-274307-kl0uvrbw	14	4	,	,	,
cord-274307-kl0uvrbw	14	5	however	however	RB
cord-274307-kl0uvrbw	14	6	,	,	,
cord-274307-kl0uvrbw	14	7	taken	take	VBN
cord-274307-kl0uvrbw	14	8	an	an	DT
cord-274307-kl0uvrbw	14	9	emotional	emotional	JJ
cord-274307-kl0uvrbw	14	10	and	and	CC
cord-274307-kl0uvrbw	14	11	claiming	claim	VBG
cord-274307-kl0uvrbw	14	12	side	side	NN
cord-274307-kl0uvrbw	14	13	in	in	IN
cord-274307-kl0uvrbw	14	14	the	the	DT
cord-274307-kl0uvrbw	14	15	context	context	NN
cord-274307-kl0uvrbw	14	16	of	of	IN
cord-274307-kl0uvrbw	14	17	the	the	DT
cord-274307-kl0uvrbw	14	18	anxiety	anxiety	NN
cord-274307-kl0uvrbw	14	19	and	and	CC
cord-274307-kl0uvrbw	14	20	fear	fear	NN
cord-274307-kl0uvrbw	14	21	generated	generate	VBN
cord-274307-kl0uvrbw	14	22	by	by	IN
cord-274307-kl0uvrbw	14	23	the	the	DT
cord-274307-kl0uvrbw	14	24	Covid-19	covid-19	NN
cord-274307-kl0uvrbw	14	25	pandemic	pandemic	NN
cord-274307-kl0uvrbw	14	26	and	and	CC
cord-274307-kl0uvrbw	14	27	its	-PRON-	PRP$
cord-274307-kl0uvrbw	14	28	lethal	lethal	JJ
cord-274307-kl0uvrbw	14	29	risk	risk	NN
cord-274307-kl0uvrbw	14	30	.	.	.
cord-274307-kl0uvrbw	15	1	Empiricism	empiricism	NN
cord-274307-kl0uvrbw	15	2	seems	seem	VBZ
cord-274307-kl0uvrbw	15	3	to	to	TO
cord-274307-kl0uvrbw	15	4	be	be	VB
cord-274307-kl0uvrbw	15	5	trying	try	VBG
cord-274307-kl0uvrbw	15	6	to	to	TO
cord-274307-kl0uvrbw	15	7	take	take	VB
cord-274307-kl0uvrbw	15	8	again	again	RB
cord-274307-kl0uvrbw	15	9	a	a	DT
cord-274307-kl0uvrbw	15	10	top	top	JJ
cord-274307-kl0uvrbw	15	11	position	position	NN
cord-274307-kl0uvrbw	15	12	over	over	IN
cord-274307-kl0uvrbw	15	13	the	the	DT
cord-274307-kl0uvrbw	15	14	rational	rational	JJ
cord-274307-kl0uvrbw	15	15	approach	approach	NN
cord-274307-kl0uvrbw	15	16	,	,	,
cord-274307-kl0uvrbw	15	17	which	which	WDT
cord-274307-kl0uvrbw	15	18	some	some	DT
cord-274307-kl0uvrbw	15	19	consider	consider	VBP
cord-274307-kl0uvrbw	15	20	too	too	RB
cord-274307-kl0uvrbw	15	21	dogmatic	dogmatic	JJ
cord-274307-kl0uvrbw	15	22	,	,	,
cord-274307-kl0uvrbw	15	23	especially	especially	RB
cord-274307-kl0uvrbw	15	24	in	in	IN
cord-274307-kl0uvrbw	15	25	critical	critical	JJ
cord-274307-kl0uvrbw	15	26	situations	situation	NNS
cord-274307-kl0uvrbw	15	27	.	.	.
cord-274307-kl0uvrbw	16	1	Is	be	VBZ
cord-274307-kl0uvrbw	16	2	it	-PRON-	PRP
cord-274307-kl0uvrbw	16	3	necessary	necessary	JJ
cord-274307-kl0uvrbw	16	4	,	,	,
cord-274307-kl0uvrbw	16	5	because	because	IN
cord-274307-kl0uvrbw	16	6	it	-PRON-	PRP
cord-274307-kl0uvrbw	16	7	is	be	VBZ
cord-274307-kl0uvrbw	16	8	urgent	urgent	JJ
cord-274307-kl0uvrbw	16	9	,	,	,
cord-274307-kl0uvrbw	16	10	to	to	TO
cord-274307-kl0uvrbw	16	11	abandon	abandon	VB
cord-274307-kl0uvrbw	16	12	all	all	PDT
cord-274307-kl0uvrbw	16	13	the	the	DT
cord-274307-kl0uvrbw	16	14	scientific	scientific	JJ
cord-274307-kl0uvrbw	16	15	principles	principle	NNS
cord-274307-kl0uvrbw	16	16	of	of	IN
cord-274307-kl0uvrbw	16	17	clinical	clinical	JJ
cord-274307-kl0uvrbw	16	18	trials	trial	NNS
cord-274307-kl0uvrbw	16	19	that	that	WDT
cord-274307-kl0uvrbw	16	20	have	have	VBP
cord-274307-kl0uvrbw	16	21	previously	previously	RB
cord-274307-kl0uvrbw	16	22	led	lead	VBN
cord-274307-kl0uvrbw	16	23	to	to	IN
cord-274307-kl0uvrbw	16	24	undeniable	undeniable	JJ
cord-274307-kl0uvrbw	16	25	therapeutic	therapeutic	JJ
cord-274307-kl0uvrbw	16	26	progress	progress	NN
cord-274307-kl0uvrbw	16	27	?	?	.
cord-274307-kl0uvrbw	17	1	Undoubtedly	undoubtedly	RB
cord-274307-kl0uvrbw	17	2	not	not	RB
cord-274307-kl0uvrbw	17	3	,	,	,
cord-274307-kl0uvrbw	17	4	which	which	WDT
cord-274307-kl0uvrbw	17	5	does	do	VBZ
cord-274307-kl0uvrbw	17	6	not	not	RB
cord-274307-kl0uvrbw	17	7	mean	mean	VB
cord-274307-kl0uvrbw	17	8	that	that	IN
cord-274307-kl0uvrbw	17	9	the	the	DT
cord-274307-kl0uvrbw	17	10	experimental	experimental	JJ
cord-274307-kl0uvrbw	17	11	design	design	NN
cord-274307-kl0uvrbw	17	12	of	of	IN
cord-274307-kl0uvrbw	17	13	the	the	DT
cord-274307-kl0uvrbw	17	14	trials	trial	NNS
cord-274307-kl0uvrbw	17	15	should	should	MD
cord-274307-kl0uvrbw	17	16	not	not	RB
cord-274307-kl0uvrbw	17	17	be	be	VB
cord-274307-kl0uvrbw	17	18	adapted	adapt	VBN
cord-274307-kl0uvrbw	17	19	,	,	,
cord-274307-kl0uvrbw	17	20	in	in	IN
cord-274307-kl0uvrbw	17	21	an	an	DT
cord-274307-kl0uvrbw	17	22	approach	approach	NN
cord-274307-kl0uvrbw	17	23	reminiscent	reminiscent	JJ
cord-274307-kl0uvrbw	17	24	of	of	IN
cord-274307-kl0uvrbw	17	25	Charles	Charles	NNP
cord-274307-kl0uvrbw	17	26	Peirce	Peirce	NNP
cord-274307-kl0uvrbw	17	27	and	and	CC
cord-274307-kl0uvrbw	17	28	William	William	NNP
cord-274307-kl0uvrbw	17	29	James	James	NNP
cord-274307-kl0uvrbw	17	30	theorising	theorise	VBG
cord-274307-kl0uvrbw	17	31	pragmatism	pragmatism	NN
cord-274307-kl0uvrbw	17	32	as	as	IN
cord-274307-kl0uvrbw	17	33	a	a	DT
cord-274307-kl0uvrbw	17	34	third	third	JJ
cord-274307-kl0uvrbw	17	35	way	way	NN
cord-274307-kl0uvrbw	17	36	transcending	transcend	VBG
cord-274307-kl0uvrbw	17	37	the	the	DT
cord-274307-kl0uvrbw	17	38	empiricism	empiricism	NN
cord-274307-kl0uvrbw	17	39	/	/	SYM
cord-274307-kl0uvrbw	17	40	rationalism	rationalism	NN
cord-274307-kl0uvrbw	17	41	opposition	opposition	NN
cord-274307-kl0uvrbw	17	42	.	.	.
cord-274307-kl0uvrbw	18	1	For	for	IN
cord-274307-kl0uvrbw	18	2	more	more	JJR
cord-274307-kl0uvrbw	18	3	than	than	IN
cord-274307-kl0uvrbw	18	4	thirty	thirty	CD
cord-274307-kl0uvrbw	18	5	years	year	NNS
cord-274307-kl0uvrbw	18	6	,	,	,
cord-274307-kl0uvrbw	18	7	French	french	JJ
cord-274307-kl0uvrbw	18	8	medical	medical	JJ
cord-274307-kl0uvrbw	18	9	pharmacologists	pharmacologist	NNS
cord-274307-kl0uvrbw	18	10	and	and	CC
cord-274307-kl0uvrbw	18	11	therapists	therapist	NNS
cord-274307-kl0uvrbw	18	12	have	have	VBP
cord-274307-kl0uvrbw	18	13	been	be	VBN
cord-274307-kl0uvrbw	18	14	contributing	contribute	VBG
cord-274307-kl0uvrbw	18	15	to	to	IN
cord-274307-kl0uvrbw	18	16	an	an	DT
cord-274307-kl0uvrbw	18	17	international	international	JJ
cord-274307-kl0uvrbw	18	18	movement	movement	NN
cord-274307-kl0uvrbw	18	19	of	of	IN
cord-274307-kl0uvrbw	18	20	methodological	methodological	JJ
cord-274307-kl0uvrbw	18	21	diversification	diversification	NN
cord-274307-kl0uvrbw	18	22	through	through	IN
cord-274307-kl0uvrbw	18	23	a	a	DT
cord-274307-kl0uvrbw	18	24	think	think	NN
cord-274307-kl0uvrbw	18	25	tank	tank	NN
cord-274307-kl0uvrbw	18	26	(	(	-LRB-
cord-274307-kl0uvrbw	18	27	called	call	VBN
cord-274307-kl0uvrbw	18	28	"	"	``
cord-274307-kl0uvrbw	18	29	Ateliers	Ateliers	NNP
cord-274307-kl0uvrbw	18	30	de	de	NNP
cord-274307-kl0uvrbw	18	31	Giens	Giens	NNP
cord-274307-kl0uvrbw	18	32	"	"	''
cord-274307-kl0uvrbw	18	33	)	)	-RRB-
cord-274307-kl0uvrbw	18	34	bringing	bring	VBG
cord-274307-kl0uvrbw	18	35	together	together	RP
cord-274307-kl0uvrbw	18	36	the	the	DT
cord-274307-kl0uvrbw	18	37	academic	academic	JJ
cord-274307-kl0uvrbw	18	38	,	,	,
cord-274307-kl0uvrbw	18	39	industrial	industrial	JJ
cord-274307-kl0uvrbw	18	40	and	and	CC
cord-274307-kl0uvrbw	18	41	institutional	institutional	JJ
cord-274307-kl0uvrbw	18	42	worlds	world	NNS
cord-274307-kl0uvrbw	18	43	.	.	.
cord-274307-kl0uvrbw	19	1	Pragmatic	pragmatic	JJ
cord-274307-kl0uvrbw	19	2	trials	trial	NNS
cord-274307-kl0uvrbw	19	3	,	,	,
cord-274307-kl0uvrbw	19	4	adaptive	adaptive	JJ
cord-274307-kl0uvrbw	19	5	trials	trial	NNS
cord-274307-kl0uvrbw	19	6	using	use	VBG
cord-274307-kl0uvrbw	19	7	the	the	DT
cord-274307-kl0uvrbw	19	8	Bayesian	bayesian	JJ
cord-274307-kl0uvrbw	19	9	approach	approach	NN
cord-274307-kl0uvrbw	19	10	,	,	,
cord-274307-kl0uvrbw	19	11	studies	study	NNS
cord-274307-kl0uvrbw	19	12	with	with	IN
cord-274307-kl0uvrbw	19	13	external	external	JJ
cord-274307-kl0uvrbw	19	14	comparators	comparator	NNS
cord-274307-kl0uvrbw	19	15	,	,	,
cord-274307-kl0uvrbw	19	16	trials	trial	NNS
cord-274307-kl0uvrbw	19	17	on	on	IN
cord-274307-kl0uvrbw	19	18	small	small	JJ
cord-274307-kl0uvrbw	19	19	samples	sample	NNS
cord-274307-kl0uvrbw	19	20	,	,	,
cord-274307-kl0uvrbw	19	21	taking	take	VBG
cord-274307-kl0uvrbw	19	22	into	into	IN
cord-274307-kl0uvrbw	19	23	account	account	NN
cord-274307-kl0uvrbw	19	24	secondary	secondary	JJ
cord-274307-kl0uvrbw	19	25	assessment	assessment	NN
cord-274307-kl0uvrbw	19	26	criteria	criterion	NNS
cord-274307-kl0uvrbw	19	27	and	and	CC
cord-274307-kl0uvrbw	19	28	the	the	DT
cord-274307-kl0uvrbw	19	29	use	use	NN
cord-274307-kl0uvrbw	19	30	of	of	IN
cord-274307-kl0uvrbw	19	31	biomarkers	biomarker	NNS
cord-274307-kl0uvrbw	19	32	are	be	VBP
cord-274307-kl0uvrbw	19	33	all	all	DT
cord-274307-kl0uvrbw	19	34	methodological	methodological	JJ
cord-274307-kl0uvrbw	19	35	innovations	innovation	NNS
cord-274307-kl0uvrbw	19	36	that	that	WDT
cord-274307-kl0uvrbw	19	37	aim	aim	VBP
cord-274307-kl0uvrbw	19	38	to	to	TO
cord-274307-kl0uvrbw	19	39	make	make	VB
cord-274307-kl0uvrbw	19	40	the	the	DT
cord-274307-kl0uvrbw	19	41	framework	framework	NN
cord-274307-kl0uvrbw	19	42	of	of	IN
cord-274307-kl0uvrbw	19	43	controlled	control	VBN
cord-274307-kl0uvrbw	19	44	trials	trial	NNS
cord-274307-kl0uvrbw	19	45	more	more	RBR
cord-274307-kl0uvrbw	19	46	flexible	flexible	JJ
cord-274307-kl0uvrbw	19	47	in	in	IN
cord-274307-kl0uvrbw	19	48	order	order	NN
cord-274307-kl0uvrbw	19	49	to	to	TO
cord-274307-kl0uvrbw	19	50	speed	speed	VB
cord-274307-kl0uvrbw	19	51	up	up	RP
cord-274307-kl0uvrbw	19	52	or	or	CC
cord-274307-kl0uvrbw	19	53	improve	improve	VB
cord-274307-kl0uvrbw	19	54	the	the	DT
cord-274307-kl0uvrbw	19	55	evaluation	evaluation	NN
cord-274307-kl0uvrbw	19	56	of	of	IN
cord-274307-kl0uvrbw	19	57	drugs	drug	NNS
cord-274307-kl0uvrbw	19	58	,	,	,
cord-274307-kl0uvrbw	19	59	without	without	IN
cord-274307-kl0uvrbw	19	60	abandoning	abandon	VBG
cord-274307-kl0uvrbw	19	61	the	the	DT
cord-274307-kl0uvrbw	19	62	major	major	JJ
cord-274307-kl0uvrbw	19	63	and	and	CC
cord-274307-kl0uvrbw	19	64	basic	basic	JJ
cord-274307-kl0uvrbw	19	65	principle	principle	NN
cord-274307-kl0uvrbw	19	66	of	of	IN
cord-274307-kl0uvrbw	19	67	comparison	comparison	NN
cord-274307-kl0uvrbw	19	68	[	[	-LRB-
cord-274307-kl0uvrbw	19	69	1	1	CD
cord-274307-kl0uvrbw	19	70	,	,	,
cord-274307-kl0uvrbw	19	71	2	2	CD
cord-274307-kl0uvrbw	19	72	]	]	-RRB-
cord-274307-kl0uvrbw	19	73	.	.	.
cord-274307-kl0uvrbw	20	1	The	the	DT
cord-274307-kl0uvrbw	20	2	media	medium	NNS
cord-274307-kl0uvrbw	20	3	outburst	outburst	NN
cord-274307-kl0uvrbw	20	4	against	against	IN
cord-274307-kl0uvrbw	20	5	methodology	methodology	NN
cord-274307-kl0uvrbw	20	6	rightly	rightly	RB
cord-274307-kl0uvrbw	20	7	clashes	clash	VBZ
cord-274307-kl0uvrbw	20	8	with	with	IN
cord-274307-kl0uvrbw	20	9	the	the	DT
cord-274307-kl0uvrbw	20	10	convictions	conviction	NNS
cord-274307-kl0uvrbw	20	11	of	of	IN
cord-274307-kl0uvrbw	20	12	the	the	DT
cord-274307-kl0uvrbw	20	13	vast	vast	JJ
cord-274307-kl0uvrbw	20	14	majority	majority	NN
cord-274307-kl0uvrbw	20	15	of	of	IN
cord-274307-kl0uvrbw	20	16	health	health	NN
cord-274307-kl0uvrbw	20	17	professionals	professional	NNS
cord-274307-kl0uvrbw	20	18	,	,	,
cord-274307-kl0uvrbw	20	19	who	who	WP
cord-274307-kl0uvrbw	20	20	have	have	VBP
cord-274307-kl0uvrbw	20	21	perhaps	perhaps	RB
cord-274307-kl0uvrbw	20	22	not	not	RB
cord-274307-kl0uvrbw	20	23	sufficiently	sufficiently	RB
cord-274307-kl0uvrbw	20	24	integrated	integrate	VBN
cord-274307-kl0uvrbw	20	25	the	the	DT
cord-274307-kl0uvrbw	20	26	fact	fact	NN
cord-274307-kl0uvrbw	20	27	that	that	IN
cord-274307-kl0uvrbw	20	28	drugs	drug	NNS
cord-274307-kl0uvrbw	20	29	,	,	,
cord-274307-kl0uvrbw	20	30	which	which	WDT
cord-274307-kl0uvrbw	20	31	they	-PRON-	PRP
cord-274307-kl0uvrbw	20	32	consider	consider	VBP
cord-274307-kl0uvrbw	20	33	above	above	IN
cord-274307-kl0uvrbw	20	34	all	all	DT
cord-274307-kl0uvrbw	20	35	as	as	IN
cord-274307-kl0uvrbw	20	36	a	a	DT
cord-274307-kl0uvrbw	20	37	scientific	scientific	JJ
cord-274307-kl0uvrbw	20	38	object	object	NN
cord-274307-kl0uvrbw	20	39	that	that	WDT
cord-274307-kl0uvrbw	20	40	is	be	VBZ
cord-274307-kl0uvrbw	20	41	their	-PRON-	PRP$
cord-274307-kl0uvrbw	20	42	prerogative	prerogative	NN
cord-274307-kl0uvrbw	20	43	,	,	,
cord-274307-kl0uvrbw	20	44	have	have	VBP
cord-274307-kl0uvrbw	20	45	also	also	RB
cord-274307-kl0uvrbw	20	46	become	become	VBN
cord-274307-kl0uvrbw	20	47	an	an	DT
cord-274307-kl0uvrbw	20	48	issue	issue	NN
cord-274307-kl0uvrbw	20	49	that	that	IN
cord-274307-kl0uvrbw	20	50	the	the	DT
cord-274307-kl0uvrbw	20	51	social	social	JJ
cord-274307-kl0uvrbw	20	52	body	body	NN
cord-274307-kl0uvrbw	20	53	has	have	VBZ
cord-274307-kl0uvrbw	20	54	taken	take	VBN
cord-274307-kl0uvrbw	20	55	up	up	RP
cord-274307-kl0uvrbw	20	56	.	.	.
cord-274307-kl0uvrbw	21	1	It	-PRON-	PRP
cord-274307-kl0uvrbw	21	2	is	be	VBZ
cord-274307-kl0uvrbw	21	3	above	above	IN
cord-274307-kl0uvrbw	21	4	all	all	RB
cord-274307-kl0uvrbw	21	5	through	through	IN
cord-274307-kl0uvrbw	21	6	the	the	DT
cord-274307-kl0uvrbw	21	7	drug	drug	NN
cord-274307-kl0uvrbw	21	8	risk	risk	NN
cord-274307-kl0uvrbw	21	9	and	and	CC
cord-274307-kl0uvrbw	21	10	its	-PRON-	PRP$
cord-274307-kl0uvrbw	21	11	often	often	RB
cord-274307-kl0uvrbw	21	12	-	-	HYPH
cord-274307-kl0uvrbw	21	13	mediatized	mediatize	VBN
cord-274307-kl0uvrbw	21	14	affairs	affair	NNS
cord-274307-kl0uvrbw	21	15	that	that	WDT
cord-274307-kl0uvrbw	21	16	society	society	NN
cord-274307-kl0uvrbw	21	17	has	have	VBZ
cord-274307-kl0uvrbw	21	18	integrated	integrate	VBN
cord-274307-kl0uvrbw	21	19	drugs	drug	NNS
cord-274307-kl0uvrbw	21	20	as	as	IN
cord-274307-kl0uvrbw	21	21	a	a	DT
cord-274307-kl0uvrbw	21	22	social	social	JJ
cord-274307-kl0uvrbw	21	23	fact	fact	NN
cord-274307-kl0uvrbw	21	24	[	[	-LRB-
cord-274307-kl0uvrbw	21	25	3	3	CD
cord-274307-kl0uvrbw	21	26	]	]	-RRB-
cord-274307-kl0uvrbw	21	27	.	.	.
cord-274307-kl0uvrbw	22	1	The	the	DT
cord-274307-kl0uvrbw	22	2	so	so	RB
cord-274307-kl0uvrbw	22	3	-	-	HYPH
cord-274307-kl0uvrbw	22	4	called	call	VBN
cord-274307-kl0uvrbw	22	5	"	"	``
cord-274307-kl0uvrbw	22	6	Mediator	Mediator	NNP
cord-274307-kl0uvrbw	22	7	"	"	''
cord-274307-kl0uvrbw	22	8	affair	affair	NN
cord-274307-kl0uvrbw	22	9	has	have	VBZ
cord-274307-kl0uvrbw	22	10	had	have	VBN
cord-274307-kl0uvrbw	22	11	a	a	DT
cord-274307-kl0uvrbw	22	12	major	major	JJ
cord-274307-kl0uvrbw	22	13	impact	impact	NN
cord-274307-kl0uvrbw	22	14	on	on	IN
cord-274307-kl0uvrbw	22	15	populations	population	NNS
cord-274307-kl0uvrbw	22	16	,	,	,
cord-274307-kl0uvrbw	22	17	in	in	IN
cord-274307-kl0uvrbw	22	18	this	this	DT
cord-274307-kl0uvrbw	22	19	case	case	NN
cord-274307-kl0uvrbw	22	20	the	the	DT
cord-274307-kl0uvrbw	22	21	French	french	JJ
cord-274307-kl0uvrbw	22	22	one	one	NN
cord-274307-kl0uvrbw	22	23	,	,	,
cord-274307-kl0uvrbw	22	24	with	with	IN
cord-274307-kl0uvrbw	22	25	the	the	DT
cord-274307-kl0uvrbw	22	26	realization	realization	NN
cord-274307-kl0uvrbw	22	27	that	that	IN
cord-274307-kl0uvrbw	22	28	drugs	drug	NNS
cord-274307-kl0uvrbw	22	29	can	can	MD
cord-274307-kl0uvrbw	22	30	be	be	VB
cord-274307-kl0uvrbw	22	31	also	also	RB
cord-274307-kl0uvrbw	22	32	dangerous	dangerous	JJ
cord-274307-kl0uvrbw	22	33	,	,	,
cord-274307-kl0uvrbw	22	34	even	even	RB
cord-274307-kl0uvrbw	22	35	in	in	IN
cord-274307-kl0uvrbw	22	36	the	the	DT
cord-274307-kl0uvrbw	22	37	long	long	JJ
cord-274307-kl0uvrbw	22	38	term	term	NN
cord-274307-kl0uvrbw	22	39	.	.	.
cord-274307-kl0uvrbw	23	1	The	the	DT
cord-274307-kl0uvrbw	23	2	front	front	JJ
cord-274307-kl0uvrbw	23	3	pages	page	NNS
cord-274307-kl0uvrbw	23	4	of	of	IN
cord-274307-kl0uvrbw	23	5	newspapers	newspaper	NNS
cord-274307-kl0uvrbw	23	6	and	and	CC
cord-274307-kl0uvrbw	23	7	magazines	magazine	NNS
cord-274307-kl0uvrbw	23	8	devoted	devote	VBN
cord-274307-kl0uvrbw	23	9	to	to	IN
cord-274307-kl0uvrbw	23	10	medicines	medicine	NNS
cord-274307-kl0uvrbw	23	11	and	and	CC
cord-274307-kl0uvrbw	23	12	their	-PRON-	PRP$
cord-274307-kl0uvrbw	23	13	risks	risk	NNS
cord-274307-kl0uvrbw	23	14	have	have	VBP
cord-274307-kl0uvrbw	23	15	been	be	VBN
cord-274307-kl0uvrbw	23	16	booming	boom	VBG
cord-274307-kl0uvrbw	23	17	,	,	,
cord-274307-kl0uvrbw	23	18	like	like	IN
cord-274307-kl0uvrbw	23	19	the	the	DT
cord-274307-kl0uvrbw	23	20	questions	question	NNS
cord-274307-kl0uvrbw	23	21	addressed	address	VBN
cord-274307-kl0uvrbw	23	22	to	to	IN
cord-274307-kl0uvrbw	23	23	the	the	DT
cord-274307-kl0uvrbw	23	24	Regional	Regional	NNP
cord-274307-kl0uvrbw	23	25	Pharmacovigilance	Pharmacovigilance	NNP
cord-274307-kl0uvrbw	23	26	Centres	Centres	NNPS
cord-274307-kl0uvrbw	23	27	.	.	.
cord-274307-kl0uvrbw	24	1	The	the	DT
cord-274307-kl0uvrbw	24	2	development	development	NN
cord-274307-kl0uvrbw	24	3	of	of	IN
cord-274307-kl0uvrbw	24	4	social	social	JJ
cord-274307-kl0uvrbw	24	5	networks	network	NNS
cord-274307-kl0uvrbw	24	6	has	have	VBZ
cord-274307-kl0uvrbw	24	7	had	have	VBN
cord-274307-kl0uvrbw	24	8	an	an	DT
cord-274307-kl0uvrbw	24	9	amplifying	amplify	VBG
cord-274307-kl0uvrbw	24	10	effect	effect	NN
cord-274307-kl0uvrbw	24	11	on	on	IN
cord-274307-kl0uvrbw	24	12	the	the	DT
cord-274307-kl0uvrbw	24	13	emergence	emergence	NN
cord-274307-kl0uvrbw	24	14	of	of	IN
cord-274307-kl0uvrbw	24	15	medicines	medicine	NNS
cord-274307-kl0uvrbw	24	16	as	as	IN
cord-274307-kl0uvrbw	24	17	a	a	DT
cord-274307-kl0uvrbw	24	18	social	social	JJ
cord-274307-kl0uvrbw	24	19	issue	issue	NN
cord-274307-kl0uvrbw	24	20	,	,	,
cord-274307-kl0uvrbw	24	21	by	by	IN
cord-274307-kl0uvrbw	24	22	bringing	bring	VBG
cord-274307-kl0uvrbw	24	23	it	-PRON-	PRP
cord-274307-kl0uvrbw	24	24	out	out	IN
cord-274307-kl0uvrbw	24	25	of	of	IN
cord-274307-kl0uvrbw	24	26	the	the	DT
cord-274307-kl0uvrbw	24	27	circle	circle	NN
cord-274307-kl0uvrbw	24	28	of	of	IN
cord-274307-kl0uvrbw	24	29	health	health	NN
cord-274307-kl0uvrbw	24	30	professionals	professional	NNS
cord-274307-kl0uvrbw	24	31	,	,	,
cord-274307-kl0uvrbw	24	32	previously	previously	RB
cord-274307-kl0uvrbw	24	33	considered	consider	VBN
cord-274307-kl0uvrbw	24	34	as	as	IN
cord-274307-kl0uvrbw	24	35	the	the	DT
cord-274307-kl0uvrbw	24	36	only	only	JJ
cord-274307-kl0uvrbw	24	37	"	"	``
cord-274307-kl0uvrbw	24	38	knowers	knower	NNS
cord-274307-kl0uvrbw	24	39	"	"	''
cord-274307-kl0uvrbw	24	40	.	.	.
cord-274307-kl0uvrbw	25	1	Some	some	DT
cord-274307-kl0uvrbw	25	2	years	year	NNS
cord-274307-kl0uvrbw	25	3	ago	ago	RB
cord-274307-kl0uvrbw	25	4	,	,	,
cord-274307-kl0uvrbw	25	5	several	several	JJ
cord-274307-kl0uvrbw	25	6	episodes	episode	NNS
cord-274307-kl0uvrbw	25	7	of	of	IN
cord-274307-kl0uvrbw	25	8	reporting	report	VBG
cord-274307-kl0uvrbw	25	9	adverse	adverse	JJ
cord-274307-kl0uvrbw	25	10	drug	drug	NN
cord-274307-kl0uvrbw	25	11	reactions	reaction	NNS
cord-274307-kl0uvrbw	25	12	linked	link	VBN
cord-274307-kl0uvrbw	25	13	to	to	IN
cord-274307-kl0uvrbw	25	14	changes	change	NNS
cord-274307-kl0uvrbw	25	15	in	in	IN
cord-274307-kl0uvrbw	25	16	thyroid	thyroid	JJ
cord-274307-kl0uvrbw	25	17	hormone	hormone	NN
cord-274307-kl0uvrbw	25	18	formulation	formulation	NN
cord-274307-kl0uvrbw	25	19	have	have	VBP
cord-274307-kl0uvrbw	25	20	emerged	emerge	VBN
cord-274307-kl0uvrbw	25	21	as	as	IN
cord-274307-kl0uvrbw	25	22	a	a	DT
cord-274307-kl0uvrbw	25	23	viral	viral	JJ
cord-274307-kl0uvrbw	25	24	relay	relay	NN
cord-274307-kl0uvrbw	25	25	on	on	IN
cord-274307-kl0uvrbw	25	26	social	social	JJ
cord-274307-kl0uvrbw	25	27	networks	network	NNS
cord-274307-kl0uvrbw	25	28	.	.	.
cord-274307-kl0uvrbw	26	1	Social	social	JJ
cord-274307-kl0uvrbw	26	2	demand	demand	NN
cord-274307-kl0uvrbw	26	3	may	may	MD
cord-274307-kl0uvrbw	26	4	lead	lead	VB
cord-274307-kl0uvrbw	26	5	regulatory	regulatory	JJ
cord-274307-kl0uvrbw	26	6	agencies	agency	NNS
cord-274307-kl0uvrbw	26	7	to	to	TO
cord-274307-kl0uvrbw	26	8	re	re	VB
cord-274307-kl0uvrbw	26	9	-	-	VB
cord-274307-kl0uvrbw	26	10	evaluate	evaluate	VB
cord-274307-kl0uvrbw	26	11	positions	position	NNS
cord-274307-kl0uvrbw	26	12	that	that	WDT
cord-274307-kl0uvrbw	26	13	were	be	VBD
cord-274307-kl0uvrbw	26	14	initially	initially	RB
cord-274307-kl0uvrbw	26	15	scientifically	scientifically	RB
cord-274307-kl0uvrbw	26	16	based	base	VBN
cord-274307-kl0uvrbw	26	17	,	,	,
cord-274307-kl0uvrbw	26	18	or	or	CC
cord-274307-kl0uvrbw	26	19	to	to	TO
cord-274307-kl0uvrbw	26	20	speed	speed	VB
cord-274307-kl0uvrbw	26	21	up	up	RP
cord-274307-kl0uvrbw	26	22	market	market	NN
cord-274307-kl0uvrbw	26	23	entry	entry	NN
cord-274307-kl0uvrbw	26	24	.	.	.
cord-274307-kl0uvrbw	27	1	Recently	recently	RB
cord-274307-kl0uvrbw	27	2	,	,	,
cord-274307-kl0uvrbw	27	3	the	the	DT
cord-274307-kl0uvrbw	27	4	film	film	NN
cord-274307-kl0uvrbw	27	5	"	"	``
cord-274307-kl0uvrbw	27	6	120	120	CD
cord-274307-kl0uvrbw	27	7	beats	beat	NNS
cord-274307-kl0uvrbw	27	8	per	per	IN
cord-274307-kl0uvrbw	27	9	minute	minute	NN
cord-274307-kl0uvrbw	27	10	"	"	''
cord-274307-kl0uvrbw	27	11	recalled	recall	VBD
cord-274307-kl0uvrbw	27	12	the	the	DT
cord-274307-kl0uvrbw	27	13	interactions	interaction	NNS
cord-274307-kl0uvrbw	27	14	,	,	,
cord-274307-kl0uvrbw	27	15	sometimes	sometimes	RB
cord-274307-kl0uvrbw	27	16	violent	violent	JJ
cord-274307-kl0uvrbw	27	17	,	,	,
cord-274307-kl0uvrbw	27	18	between	between	IN
cord-274307-kl0uvrbw	27	19	patient	patient	JJ
cord-274307-kl0uvrbw	27	20	associations	association	NNS
cord-274307-kl0uvrbw	27	21	,	,	,
cord-274307-kl0uvrbw	27	22	pharmaceutical	pharmaceutical	NN
cord-274307-kl0uvrbw	27	23	industry	industry	NN
cord-274307-kl0uvrbw	27	24	and	and	CC
cord-274307-kl0uvrbw	27	25	regulatory	regulatory	JJ
cord-274307-kl0uvrbw	27	26	agencies	agency	NNS
cord-274307-kl0uvrbw	27	27	in	in	IN
cord-274307-kl0uvrbw	27	28	order	order	NN
cord-274307-kl0uvrbw	27	29	to	to	TO
cord-274307-kl0uvrbw	27	30	bypass	bypass	VB
cord-274307-kl0uvrbw	27	31	the	the	DT
cord-274307-kl0uvrbw	27	32	usual	usual	JJ
cord-274307-kl0uvrbw	27	33	marketing	marketing	NN
cord-274307-kl0uvrbw	27	34	rules	rule	NNS
cord-274307-kl0uvrbw	27	35	,	,	,
cord-274307-kl0uvrbw	27	36	in	in	IN
cord-274307-kl0uvrbw	27	37	view	view	NN
cord-274307-kl0uvrbw	27	38	of	of	IN
cord-274307-kl0uvrbw	27	39	the	the	DT
cord-274307-kl0uvrbw	27	40	mortality	mortality	NN
cord-274307-kl0uvrbw	27	41	caused	cause	VBN
cord-274307-kl0uvrbw	27	42	by	by	IN
cord-274307-kl0uvrbw	27	43	HIV	HIV	NNP
cord-274307-kl0uvrbw	27	44	.	.	.
cord-274307-kl0uvrbw	28	1	This	this	DT
cord-274307-kl0uvrbw	28	2	is	be	VBZ
cord-274307-kl0uvrbw	28	3	reminiscent	reminiscent	JJ
cord-274307-kl0uvrbw	28	4	of	of	IN
cord-274307-kl0uvrbw	28	5	what	what	WP
cord-274307-kl0uvrbw	28	6	we	-PRON-	PRP
cord-274307-kl0uvrbw	28	7	are	be	VBP
cord-274307-kl0uvrbw	28	8	experiencing	experience	VBG
cord-274307-kl0uvrbw	28	9	today	today	NN
cord-274307-kl0uvrbw	28	10	with	with	IN
cord-274307-kl0uvrbw	28	11	molecules	molecule	NNS
cord-274307-kl0uvrbw	28	12	reputed	repute	VBN
cord-274307-kl0uvrbw	28	13	to	to	TO
cord-274307-kl0uvrbw	28	14	be	be	VB
cord-274307-kl0uvrbw	28	15	potentially	potentially	RB
cord-274307-kl0uvrbw	28	16	effective	effective	JJ
cord-274307-kl0uvrbw	28	17	against	against	IN
cord-274307-kl0uvrbw	28	18	SARS	SARS	NNP
cord-274307-kl0uvrbw	28	19	-	-	HYPH
cord-274307-kl0uvrbw	28	20	Cov-2	Cov-2	NNP
cord-274307-kl0uvrbw	28	21	,	,	,
cord-274307-kl0uvrbw	28	22	recalling	recall	VBG
cord-274307-kl0uvrbw	28	23	what	what	WP
cord-274307-kl0uvrbw	28	24	we	-PRON-	PRP
cord-274307-kl0uvrbw	28	25	have	have	VBP
cord-274307-kl0uvrbw	28	26	previously	previously	RB
cord-274307-kl0uvrbw	28	27	seen	see	VBN
cord-274307-kl0uvrbw	28	28	with	with	IN
cord-274307-kl0uvrbw	28	29	other	other	JJ
cord-274307-kl0uvrbw	28	30	products	product	NNS
cord-274307-kl0uvrbw	28	31	,	,	,
cord-274307-kl0uvrbw	28	32	such	such	JJ
cord-274307-kl0uvrbw	28	33	as	as	IN
cord-274307-kl0uvrbw	28	34	baclofen	baclofen	NN
cord-274307-kl0uvrbw	28	35	in	in	IN
cord-274307-kl0uvrbw	28	36	alcohol	alcohol	NN
cord-274307-kl0uvrbw	28	37	use	use	NN
cord-274307-kl0uvrbw	28	38	disorders	disorder	NNS
cord-274307-kl0uvrbw	28	39	.	.	.
cord-274307-kl0uvrbw	29	1	While	while	IN
cord-274307-kl0uvrbw	29	2	society	society	NN
cord-274307-kl0uvrbw	29	3	may	may	MD
cord-274307-kl0uvrbw	29	4	request	request	VB
cord-274307-kl0uvrbw	29	5	answers	answer	NNS
cord-274307-kl0uvrbw	29	6	from	from	IN
cord-274307-kl0uvrbw	29	7	public	public	JJ
cord-274307-kl0uvrbw	29	8	authorities	authority	NNS
cord-274307-kl0uvrbw	29	9	and	and	CC
cord-274307-kl0uvrbw	29	10	healthcare	healthcare	NN
cord-274307-kl0uvrbw	29	11	professionals	professional	NNS
cord-274307-kl0uvrbw	29	12	regarding	regard	VBG
cord-274307-kl0uvrbw	29	13	the	the	DT
cord-274307-kl0uvrbw	29	14	risks	risk	NNS
cord-274307-kl0uvrbw	29	15	/	/	SYM
cord-274307-kl0uvrbw	29	16	benefits	benefit	NNS
cord-274307-kl0uvrbw	29	17	balance	balance	NN
cord-274307-kl0uvrbw	29	18	of	of	IN
cord-274307-kl0uvrbw	29	19	drugs	drug	NNS
cord-274307-kl0uvrbw	29	20	,	,	,
cord-274307-kl0uvrbw	29	21	social	social	JJ
cord-274307-kl0uvrbw	29	22	facts	fact	NNS
cord-274307-kl0uvrbw	29	23	may	may	MD
cord-274307-kl0uvrbw	29	24	also	also	RB
cord-274307-kl0uvrbw	29	25	influence	influence	VB
cord-274307-kl0uvrbw	29	26	the	the	DT
cord-274307-kl0uvrbw	29	27	medical	medical	JJ
cord-274307-kl0uvrbw	29	28	use	use	NN
cord-274307-kl0uvrbw	29	29	or	or	CC
cord-274307-kl0uvrbw	29	30	diversion	diversion	NN
cord-274307-kl0uvrbw	29	31	of	of	IN
cord-274307-kl0uvrbw	29	32	medicines	medicine	NNS
cord-274307-kl0uvrbw	29	33	,	,	,
cord-274307-kl0uvrbw	29	34	or	or	CC
cord-274307-kl0uvrbw	29	35	even	even	RB
cord-274307-kl0uvrbw	29	36	investment	investment	NN
cord-274307-kl0uvrbw	29	37	in	in	IN
cord-274307-kl0uvrbw	29	38	their	-PRON-	PRP$
cord-274307-kl0uvrbw	29	39	development	development	NN
cord-274307-kl0uvrbw	29	40	.	.	.
cord-274307-kl0uvrbw	30	1	The	the	DT
cord-274307-kl0uvrbw	30	2	cult	cult	NN
cord-274307-kl0uvrbw	30	3	of	of	IN
cord-274307-kl0uvrbw	30	4	thinness	thinness	NN
cord-274307-kl0uvrbw	30	5	,	,	,
cord-274307-kl0uvrbw	30	6	advocated	advocate	VBN
cord-274307-kl0uvrbw	30	7	year	year	NN
cord-274307-kl0uvrbw	30	8	-	-	HYPH
cord-274307-kl0uvrbw	30	9	round	round	NN
cord-274307-kl0uvrbw	30	10	in	in	IN
cord-274307-kl0uvrbw	30	11	all	all	DT
cord-274307-kl0uvrbw	30	12	magazines	magazine	NNS
cord-274307-kl0uvrbw	30	13	,	,	,
cord-274307-kl0uvrbw	30	14	was	be	VBD
cord-274307-kl0uvrbw	30	15	undoubtedly	undoubtedly	RB
cord-274307-kl0uvrbw	30	16	the	the	DT
cord-274307-kl0uvrbw	30	17	main	main	JJ
cord-274307-kl0uvrbw	30	18	factor	factor	NN
cord-274307-kl0uvrbw	30	19	that	that	WDT
cord-274307-kl0uvrbw	30	20	triggered	trigger	VBD
cord-274307-kl0uvrbw	30	21	the	the	DT
cord-274307-kl0uvrbw	30	22	misuse	misuse	NN
cord-274307-kl0uvrbw	30	23	of	of	IN
cord-274307-kl0uvrbw	30	24	the	the	DT
cord-274307-kl0uvrbw	30	25	Mediator	Mediator	NNP
cord-274307-kl0uvrbw	30	26	,	,	,
cord-274307-kl0uvrbw	30	27	replacing	replace	VBG
cord-274307-kl0uvrbw	30	28	dexfenfluramine	dexfenfluramine	NN
cord-274307-kl0uvrbw	30	29	,	,	,
cord-274307-kl0uvrbw	30	30	which	which	WDT
cord-274307-kl0uvrbw	30	31	,	,	,
cord-274307-kl0uvrbw	30	32	a	a	DT
cord-274307-kl0uvrbw	30	33	few	few	JJ
cord-274307-kl0uvrbw	30	34	years	year	NNS
cord-274307-kl0uvrbw	30	35	earlier	early	RBR
cord-274307-kl0uvrbw	30	36	,	,	,
cord-274307-kl0uvrbw	30	37	had	have	VBD
cord-274307-kl0uvrbw	30	38	been	be	VBN
cord-274307-kl0uvrbw	30	39	withdrawn	withdraw	VBN
cord-274307-kl0uvrbw	30	40	from	from	IN
cord-274307-kl0uvrbw	30	41	the	the	DT
cord-274307-kl0uvrbw	30	42	market	market	NN
cord-274307-kl0uvrbw	30	43	because	because	IN
cord-274307-kl0uvrbw	30	44	of	of	IN
cord-274307-kl0uvrbw	30	45	its	-PRON-	PRP$
cord-274307-kl0uvrbw	30	46	valvular	valvular	JJ
cord-274307-kl0uvrbw	30	47	risk	risk	NN
cord-274307-kl0uvrbw	30	48	.	.	.
cord-274307-kl0uvrbw	31	1	Our	-PRON-	PRP$
cord-274307-kl0uvrbw	31	2	modern	modern	JJ
cord-274307-kl0uvrbw	31	3	societies	society	NNS
cord-274307-kl0uvrbw	31	4	,	,	,
cord-274307-kl0uvrbw	31	5	based	base	VBN
cord-274307-kl0uvrbw	31	6	on	on	IN
cord-274307-kl0uvrbw	31	7	the	the	DT
cord-274307-kl0uvrbw	31	8	over	over	NN
cord-274307-kl0uvrbw	31	9	-	-	HYPH
cord-274307-kl0uvrbw	31	10	emphasis	emphasis	NN
cord-274307-kl0uvrbw	31	11	on	on	IN
cord-274307-kl0uvrbw	31	12	performance	performance	NN
cord-274307-kl0uvrbw	31	13	,	,	,
cord-274307-kl0uvrbw	31	14	generate	generate	VB
cord-274307-kl0uvrbw	31	15	a	a	DT
cord-274307-kl0uvrbw	31	16	diversion	diversion	NN
cord-274307-kl0uvrbw	31	17	of	of	IN
cord-274307-kl0uvrbw	31	18	drugs	drug	NNS
cord-274307-kl0uvrbw	31	19	,	,	,
cord-274307-kl0uvrbw	31	20	particularly	particularly	RB
cord-274307-kl0uvrbw	31	21	psychotropic	psychotropic	JJ
cord-274307-kl0uvrbw	31	22	ones	one	NNS
cord-274307-kl0uvrbw	31	23	,	,	,
cord-274307-kl0uvrbw	31	24	for	for	IN
cord-274307-kl0uvrbw	31	25	the	the	DT
cord-274307-kl0uvrbw	31	26	purpose	purpose	NN
cord-274307-kl0uvrbw	31	27	of	of	IN
cord-274307-kl0uvrbw	31	28	cognitive	cognitive	JJ
cord-274307-kl0uvrbw	31	29	doping	doping	NN
cord-274307-kl0uvrbw	31	30	.	.	.
cord-274307-kl0uvrbw	32	1	However	however	RB
cord-274307-kl0uvrbw	32	2	,	,	,
cord-274307-kl0uvrbw	32	3	anxiety	anxiety	NN
cord-274307-kl0uvrbw	32	4	induced	induce	VBN
cord-274307-kl0uvrbw	32	5	by	by	IN
cord-274307-kl0uvrbw	32	6	loss	loss	NN
cord-274307-kl0uvrbw	32	7	of	of	IN
cord-274307-kl0uvrbw	32	8	social	social	JJ
cord-274307-kl0uvrbw	32	9	bearings	bearing	NNS
cord-274307-kl0uvrbw	32	10	or	or	CC
cord-274307-kl0uvrbw	32	11	by	by	IN
cord-274307-kl0uvrbw	32	12	suffering	suffer	VBG
cord-274307-kl0uvrbw	32	13	at	at	IN
cord-274307-kl0uvrbw	32	14	work	work	NN
cord-274307-kl0uvrbw	32	15	linked	link	VBN
cord-274307-kl0uvrbw	32	16	to	to	IN
cord-274307-kl0uvrbw	32	17	the	the	DT
cord-274307-kl0uvrbw	32	18	search	search	NN
cord-274307-kl0uvrbw	32	19	for	for	IN
cord-274307-kl0uvrbw	32	20	profitability	profitability	NN
cord-274307-kl0uvrbw	32	21	at	at	IN
cord-274307-kl0uvrbw	32	22	all	all	DT
cord-274307-kl0uvrbw	32	23	costs	cost	NNS
cord-274307-kl0uvrbw	32	24	explains	explain	VBZ
cord-274307-kl0uvrbw	32	25	the	the	DT
cord-274307-kl0uvrbw	32	26	over	over	IN
cord-274307-kl0uvrbw	32	27	-	-	HYPH
cord-274307-kl0uvrbw	32	28	consumption	consumption	NN
cord-274307-kl0uvrbw	32	29	of	of	IN
cord-274307-kl0uvrbw	32	30	psychotropic	psychotropic	JJ
cord-274307-kl0uvrbw	32	31	tranquillizers	tranquillizer	NNS
cord-274307-kl0uvrbw	32	32	or	or	CC
cord-274307-kl0uvrbw	32	33	antidepressants	antidepressant	NNS
cord-274307-kl0uvrbw	32	34	.	.	.
cord-274307-kl0uvrbw	33	1	The	the	DT
cord-274307-kl0uvrbw	33	2	social	social	JJ
cord-274307-kl0uvrbw	33	3	context	context	NN
cord-274307-kl0uvrbw	33	4	may	may	MD
cord-274307-kl0uvrbw	33	5	therefore	therefore	RB
cord-274307-kl0uvrbw	33	6	explain	explain	VB
cord-274307-kl0uvrbw	33	7	the	the	DT
cord-274307-kl0uvrbw	33	8	emergence	emergence	NN
cord-274307-kl0uvrbw	33	9	of	of	IN
cord-274307-kl0uvrbw	33	10	a	a	DT
cord-274307-kl0uvrbw	33	11	pattern	pattern	NN
cord-274307-kl0uvrbw	33	12	of	of	IN
cord-274307-kl0uvrbw	33	13	use	use	NN
cord-274307-kl0uvrbw	33	14	or	or	CC
cord-274307-kl0uvrbw	33	15	an	an	DT
cord-274307-kl0uvrbw	33	16	increase	increase	NN
cord-274307-kl0uvrbw	33	17	in	in	IN
cord-274307-kl0uvrbw	33	18	the	the	DT
cord-274307-kl0uvrbw	33	19	prescribing	prescribing	NN
cord-274307-kl0uvrbw	33	20	or	or	CC
cord-274307-kl0uvrbw	33	21	consumption	consumption	NN
cord-274307-kl0uvrbw	33	22	of	of	IN
cord-274307-kl0uvrbw	33	23	a	a	DT
cord-274307-kl0uvrbw	33	24	particular	particular	JJ
cord-274307-kl0uvrbw	33	25	drug	drug	NN
cord-274307-kl0uvrbw	33	26	,	,	,
cord-274307-kl0uvrbw	33	27	which	which	WDT
cord-274307-kl0uvrbw	33	28	then	then	RB
cord-274307-kl0uvrbw	33	29	escapes	escape	VBZ
cord-274307-kl0uvrbw	33	30	rational	rational	JJ
cord-274307-kl0uvrbw	33	31	,	,	,
cord-274307-kl0uvrbw	33	32	evidence	evidence	NN
cord-274307-kl0uvrbw	33	33	-	-	HYPH
cord-274307-kl0uvrbw	33	34	based	base	VBN
cord-274307-kl0uvrbw	33	35	use	use	NN
cord-274307-kl0uvrbw	33	36	,	,	,
cord-274307-kl0uvrbw	33	37	necessitating	necessitate	VBG
cord-274307-kl0uvrbw	33	38	regulatory	regulatory	JJ
cord-274307-kl0uvrbw	33	39	measures	measure	NNS
cord-274307-kl0uvrbw	33	40	to	to	TO
cord-274307-kl0uvrbw	33	41	control	control	VB
cord-274307-kl0uvrbw	33	42	prescribing	prescribing	NN
cord-274307-kl0uvrbw	33	43	or	or	CC
cord-274307-kl0uvrbw	33	44	dispensing	dispensing	NN
cord-274307-kl0uvrbw	33	45	.	.	.
cord-274307-kl0uvrbw	34	1	The	the	DT
cord-274307-kl0uvrbw	34	2	current	current	JJ
cord-274307-kl0uvrbw	34	3	health	health	NN
cord-274307-kl0uvrbw	34	4	crisis	crisis	NN
cord-274307-kl0uvrbw	34	5	has	have	VBZ
cord-274307-kl0uvrbw	34	6	highlighted	highlight	VBN
cord-274307-kl0uvrbw	34	7	the	the	DT
cord-274307-kl0uvrbw	34	8	immediate	immediate	JJ
cord-274307-kl0uvrbw	34	9	link	link	NN
cord-274307-kl0uvrbw	34	10	between	between	IN
cord-274307-kl0uvrbw	34	11	the	the	DT
cord-274307-kl0uvrbw	34	12	announcement	announcement	NN
cord-274307-kl0uvrbw	34	13	of	of	IN
cord-274307-kl0uvrbw	34	14	preliminary	preliminary	JJ
cord-274307-kl0uvrbw	34	15	or	or	CC
cord-274307-kl0uvrbw	34	16	hypothetical	hypothetical	JJ
cord-274307-kl0uvrbw	34	17	results	result	NNS
cord-274307-kl0uvrbw	34	18	on	on	IN
cord-274307-kl0uvrbw	34	19	the	the	DT
cord-274307-kl0uvrbw	34	20	efficacy	efficacy	NN
cord-274307-kl0uvrbw	34	21	of	of	IN
cord-274307-kl0uvrbw	34	22	a	a	DT
cord-274307-kl0uvrbw	34	23	particular	particular	JJ
cord-274307-kl0uvrbw	34	24	drug	drug	NN
cord-274307-kl0uvrbw	34	25	against	against	IN
cord-274307-kl0uvrbw	34	26	coronavirus	coronavirus	NN
cord-274307-kl0uvrbw	34	27	and	and	CC
cord-274307-kl0uvrbw	34	28	its	-PRON-	PRP$
cord-274307-kl0uvrbw	34	29	dispensing	dispensing	NN
cord-274307-kl0uvrbw	34	30	,	,	,
cord-274307-kl0uvrbw	34	31	and	and	CC
cord-274307-kl0uvrbw	34	32	often	often	RB
cord-274307-kl0uvrbw	34	33	consumption	consumption	NN
cord-274307-kl0uvrbw	34	34	,	,	,
cord-274307-kl0uvrbw	34	35	outside	outside	RB
cord-274307-kl0uvrbw	34	36	of	of	IN
cord-274307-kl0uvrbw	34	37	any	any	DT
cord-274307-kl0uvrbw	34	38	regulatory	regulatory	JJ
cord-274307-kl0uvrbw	34	39	framework	framework	NN
cord-274307-kl0uvrbw	34	40	.	.	.
cord-274307-kl0uvrbw	35	1	Taking	take	VBG
cord-274307-kl0uvrbw	35	2	into	into	IN
cord-274307-kl0uvrbw	35	3	account	account	NN
cord-274307-kl0uvrbw	35	4	the	the	DT
cord-274307-kl0uvrbw	35	5	social	social	JJ
cord-274307-kl0uvrbw	35	6	dimension	dimension	NN
cord-274307-kl0uvrbw	35	7	of	of	IN
cord-274307-kl0uvrbw	35	8	the	the	DT
cord-274307-kl0uvrbw	35	9	drug	drug	NN
cord-274307-kl0uvrbw	35	10	reveals	reveal	NNS
cord-274307-kl0uvrbw	35	11	,	,	,
cord-274307-kl0uvrbw	35	12	however	however	RB
cord-274307-kl0uvrbw	35	13	,	,	,
cord-274307-kl0uvrbw	35	14	a	a	DT
cord-274307-kl0uvrbw	35	15	contradiction	contradiction	NN
cord-274307-kl0uvrbw	35	16	in	in	IN
cord-274307-kl0uvrbw	35	17	the	the	DT
cord-274307-kl0uvrbw	35	18	demand	demand	NN
cord-274307-kl0uvrbw	35	19	of	of	IN
cord-274307-kl0uvrbw	35	20	the	the	DT
cord-274307-kl0uvrbw	35	21	social	social	JJ
cord-274307-kl0uvrbw	35	22	body	body	NN
cord-274307-kl0uvrbw	35	23	,	,	,
cord-274307-kl0uvrbw	35	24	which	which	WDT
cord-274307-kl0uvrbw	35	25	has	have	VBZ
cord-274307-kl0uvrbw	35	26	been	be	VBN
cord-274307-kl0uvrbw	35	27	amplified	amplify	VBN
cord-274307-kl0uvrbw	35	28	during	during	IN
cord-274307-kl0uvrbw	35	29	the	the	DT
cord-274307-kl0uvrbw	35	30	health	health	NN
cord-274307-kl0uvrbw	35	31	crisis	crisis	NN
cord-274307-kl0uvrbw	35	32	.	.	.
cord-274307-kl0uvrbw	36	1	On	on	IN
cord-274307-kl0uvrbw	36	2	the	the	DT
cord-274307-kl0uvrbw	36	3	one	one	CD
cord-274307-kl0uvrbw	36	4	hand	hand	NN
cord-274307-kl0uvrbw	36	5	,	,	,
cord-274307-kl0uvrbw	36	6	there	there	EX
cord-274307-kl0uvrbw	36	7	is	be	VBZ
cord-274307-kl0uvrbw	36	8	an	an	DT
cord-274307-kl0uvrbw	36	9	expectation	expectation	NN
cord-274307-kl0uvrbw	36	10	for	for	IN
cord-274307-kl0uvrbw	36	11	information	information	NN
cord-274307-kl0uvrbw	36	12	that	that	WDT
cord-274307-kl0uvrbw	36	13	has	have	VBZ
cord-274307-kl0uvrbw	36	14	been	be	VBN
cord-274307-kl0uvrbw	36	15	scientifically	scientifically	RB
cord-274307-kl0uvrbw	36	16	validated	validate	VBN
cord-274307-kl0uvrbw	36	17	by	by	IN
cord-274307-kl0uvrbw	36	18	health	health	NN
cord-274307-kl0uvrbw	36	19	professionals	professional	NNS
cord-274307-kl0uvrbw	36	20	.	.	.
cord-274307-kl0uvrbw	37	1	In	in	IN
cord-274307-kl0uvrbw	37	2	the	the	DT
cord-274307-kl0uvrbw	37	3	space	space	NN
cord-274307-kl0uvrbw	37	4	of	of	IN
cord-274307-kl0uvrbw	37	5	one	one	CD
cord-274307-kl0uvrbw	37	6	month	month	NN
cord-274307-kl0uvrbw	37	7	,	,	,
cord-274307-kl0uvrbw	37	8	the	the	DT
cord-274307-kl0uvrbw	37	9	Pharmacovid	Pharmacovid	NNP
cord-274307-kl0uvrbw	37	10	site	site	NN
cord-274307-kl0uvrbw	37	11	[	[	-LRB-
cord-274307-kl0uvrbw	37	12	4	4	LS
cord-274307-kl0uvrbw	37	13	]	]	-RRB-
cord-274307-kl0uvrbw	37	14	set	set	VBN
cord-274307-kl0uvrbw	37	15	up	up	RP
cord-274307-kl0uvrbw	37	16	on	on	IN
cord-274307-kl0uvrbw	37	17	21	21	CD
cord-274307-kl0uvrbw	37	18	March	March	NNP
cord-274307-kl0uvrbw	37	19	was	be	VBD
cord-274307-kl0uvrbw	37	20	consulted	consult	VBN
cord-274307-kl0uvrbw	37	21	nearly	nearly	RB
cord-274307-kl0uvrbw	37	22	300,000	300,000	CD
cord-274307-kl0uvrbw	37	23	times	time	NNS
cord-274307-kl0uvrbw	37	24	,	,	,
cord-274307-kl0uvrbw	37	25	with	with	IN
cord-274307-kl0uvrbw	37	26	many	many	JJ
cord-274307-kl0uvrbw	37	27	questions	question	NNS
cord-274307-kl0uvrbw	37	28	asked	ask	VBN
cord-274307-kl0uvrbw	37	29	by	by	IN
cord-274307-kl0uvrbw	37	30	The	the	DT
cord-274307-kl0uvrbw	37	31	current	current	JJ
cord-274307-kl0uvrbw	37	32	health	health	NN
cord-274307-kl0uvrbw	37	33	crisis	crisis	NN
cord-274307-kl0uvrbw	37	34	may	may	MD
cord-274307-kl0uvrbw	37	35	be	be	VB
cord-274307-kl0uvrbw	37	36	leading	lead	VBG
cord-274307-kl0uvrbw	37	37	to	to	IN
cord-274307-kl0uvrbw	37	38	a	a	DT
cord-274307-kl0uvrbw	37	39	turning	turning	NN
cord-274307-kl0uvrbw	37	40	point	point	NN
cord-274307-kl0uvrbw	37	41	,	,	,
cord-274307-kl0uvrbw	37	42	with	with	IN
cord-274307-kl0uvrbw	37	43	drugs	drug	NNS
cord-274307-kl0uvrbw	37	44	becoming	become	VBG
cord-274307-kl0uvrbw	37	45	a	a	DT
cord-274307-kl0uvrbw	37	46	political	political	JJ
cord-274307-kl0uvrbw	37	47	football	football	NN
cord-274307-kl0uvrbw	37	48	.	.	.
cord-274307-kl0uvrbw	38	1	It	-PRON-	PRP
cord-274307-kl0uvrbw	38	2	is	be	VBZ
cord-274307-kl0uvrbw	38	3	first	first	JJ
cord-274307-kl0uvrbw	38	4	of	of	IN
cord-274307-kl0uvrbw	38	5	all	all	PDT
cord-274307-kl0uvrbw	38	6	an	an	DT
cord-274307-kl0uvrbw	38	7	object	object	NN
cord-274307-kl0uvrbw	38	8	in	in	IN
cord-274307-kl0uvrbw	38	9	the	the	DT
cord-274307-kl0uvrbw	38	10	international	international	JJ
cord-274307-kl0uvrbw	38	11	political	political	JJ
cord-274307-kl0uvrbw	38	12	games	game	NNS
cord-274307-kl0uvrbw	38	13	,	,	,
cord-274307-kl0uvrbw	38	14	because	because	IN
cord-274307-kl0uvrbw	38	15	it	-PRON-	PRP
cord-274307-kl0uvrbw	38	16	is	be	VBZ
cord-274307-kl0uvrbw	38	17	clear	clear	JJ
cord-274307-kl0uvrbw	38	18	that	that	IN
cord-274307-kl0uvrbw	38	19	States	state	NNS
cord-274307-kl0uvrbw	38	20	have	have	VBP
cord-274307-kl0uvrbw	38	21	lost	lose	VBN
cord-274307-kl0uvrbw	38	22	their	-PRON-	PRP$
cord-274307-kl0uvrbw	38	23	sovereignty	sovereignty	NN
cord-274307-kl0uvrbw	38	24	over	over	IN
cord-274307-kl0uvrbw	38	25	the	the	DT
cord-274307-kl0uvrbw	38	26	production	production	NN
cord-274307-kl0uvrbw	38	27	of	of	IN
cord-274307-kl0uvrbw	38	28	medicines	medicine	NNS
cord-274307-kl0uvrbw	38	29	,	,	,
cord-274307-kl0uvrbw	38	30	which	which	WDT
cord-274307-kl0uvrbw	38	31	,	,	,
cord-274307-kl0uvrbw	38	32	like	like	IN
cord-274307-kl0uvrbw	38	33	other	other	JJ
cord-274307-kl0uvrbw	38	34	manufactured	manufacture	VBN
cord-274307-kl0uvrbw	38	35	products	product	NNS
cord-274307-kl0uvrbw	38	36	,	,	,
cord-274307-kl0uvrbw	38	37	has	have	VBZ
cord-274307-kl0uvrbw	38	38	become	become	VBN
cord-274307-kl0uvrbw	38	39	one	one	CD
cord-274307-kl0uvrbw	38	40	of	of	IN
cord-274307-kl0uvrbw	38	41	the	the	DT
cord-274307-kl0uvrbw	38	42	goods	good	NNS
cord-274307-kl0uvrbw	38	43	of	of	IN
cord-274307-kl0uvrbw	38	44	globalized	globalized	JJ
cord-274307-kl0uvrbw	38	45	capitalism	capitalism	NN
cord-274307-kl0uvrbw	38	46	.	.	.
cord-274307-kl0uvrbw	39	1	The	the	DT
cord-274307-kl0uvrbw	39	2	current	current	JJ
cord-274307-kl0uvrbw	39	3	crisis	crisis	NN
cord-274307-kl0uvrbw	39	4	,	,	,
cord-274307-kl0uvrbw	39	5	however	however	RB
cord-274307-kl0uvrbw	39	6	,	,	,
cord-274307-kl0uvrbw	39	7	has	have	VBZ
cord-274307-kl0uvrbw	39	8	made	make	VBN
cord-274307-kl0uvrbw	39	9	us	-PRON-	PRP
cord-274307-kl0uvrbw	39	10	aware	aware	JJ
cord-274307-kl0uvrbw	39	11	that	that	IN
cord-274307-kl0uvrbw	39	12	drugs	drug	NNS
cord-274307-kl0uvrbw	39	13	are	be	VBP
cord-274307-kl0uvrbw	39	14	above	above	IN
cord-274307-kl0uvrbw	39	15	all	all	PDT
cord-274307-kl0uvrbw	39	16	a	a	DT
cord-274307-kl0uvrbw	39	17	common	common	JJ
cord-274307-kl0uvrbw	39	18	good	good	NN
cord-274307-kl0uvrbw	39	19	,	,	,
cord-274307-kl0uvrbw	39	20	since	since	IN
cord-274307-kl0uvrbw	39	21	they	-PRON-	PRP
cord-274307-kl0uvrbw	39	22	affect	affect	VBP
cord-274307-kl0uvrbw	39	23	one	one	CD
cord-274307-kl0uvrbw	39	24	of	of	IN
cord-274307-kl0uvrbw	39	25	the	the	DT
cord-274307-kl0uvrbw	39	26	essential	essential	JJ
cord-274307-kl0uvrbw	39	27	elements	element	NNS
cord-274307-kl0uvrbw	39	28	for	for	IN
cord-274307-kl0uvrbw	39	29	humanity	humanity	NN
cord-274307-kl0uvrbw	39	30	,	,	,
cord-274307-kl0uvrbw	39	31	namely	namely	RB
cord-274307-kl0uvrbw	39	32	health	health	NN
cord-274307-kl0uvrbw	39	33	.	.	.
cord-274307-kl0uvrbw	40	1	If	if	IN
cord-274307-kl0uvrbw	40	2	tomorrow	tomorrow	NN
cord-274307-kl0uvrbw	40	3	a	a	DT
cord-274307-kl0uvrbw	40	4	vaccine	vaccine	NN
cord-274307-kl0uvrbw	40	5	or	or	CC
cord-274307-kl0uvrbw	40	6	treatment	treatment	NN
cord-274307-kl0uvrbw	40	7	against	against	IN
cord-274307-kl0uvrbw	40	8	coronavirus	coronavirus	NN
cord-274307-kl0uvrbw	40	9	is	be	VBZ
cord-274307-kl0uvrbw	40	10	found	find	VBN
cord-274307-kl0uvrbw	40	11	,	,	,
cord-274307-kl0uvrbw	40	12	will	will	MD
cord-274307-kl0uvrbw	40	13	we	-PRON-	PRP
cord-274307-kl0uvrbw	40	14	witness	witness	VB
cord-274307-kl0uvrbw	40	15	a	a	DT
cord-274307-kl0uvrbw	40	16	war	war	NN
cord-274307-kl0uvrbw	40	17	between	between	IN
cord-274307-kl0uvrbw	40	18	states	state	NNS
cord-274307-kl0uvrbw	40	19	to	to	TO
cord-274307-kl0uvrbw	40	20	control	control	VB
cord-274307-kl0uvrbw	40	21	supply	supply	NN
cord-274307-kl0uvrbw	40	22	,	,	,
cord-274307-kl0uvrbw	40	23	as	as	IN
cord-274307-kl0uvrbw	40	24	happened	happen	VBN
cord-274307-kl0uvrbw	40	25	with	with	IN
cord-274307-kl0uvrbw	40	26	masks	mask	NNS
cord-274307-kl0uvrbw	40	27	?	?	.
cord-274307-kl0uvrbw	41	1	Will	Will	MD
cord-274307-kl0uvrbw	41	2	the	the	DT
cord-274307-kl0uvrbw	41	3	world	world	NN
cord-274307-kl0uvrbw	41	4	balance	balance	NN
cord-274307-kl0uvrbw	41	5	between	between	IN
cord-274307-kl0uvrbw	41	6	states	state	NNS
cord-274307-kl0uvrbw	41	7	be	be	VB
cord-274307-kl0uvrbw	41	8	altered	alter	VBN
cord-274307-kl0uvrbw	41	9	?	?	.
cord-274307-kl0uvrbw	42	1	Will	Will	MD
cord-274307-kl0uvrbw	42	2	the	the	DT
cord-274307-kl0uvrbw	42	3	ability	ability	NN
cord-274307-kl0uvrbw	42	4	to	to	TO
cord-274307-kl0uvrbw	42	5	control	control	VB
cord-274307-kl0uvrbw	42	6	drug	drug	NN
cord-274307-kl0uvrbw	42	7	policy	policy	NN
cord-274307-kl0uvrbw	42	8	in	in	IN
cord-274307-kl0uvrbw	42	9	all	all	PDT
cord-274307-kl0uvrbw	42	10	its	-PRON-	PRP$
cord-274307-kl0uvrbw	42	11	aspects	aspect	NNS
cord-274307-kl0uvrbw	42	12	(	(	-LRB-
cord-274307-kl0uvrbw	42	13	innovation	innovation	NN
cord-274307-kl0uvrbw	42	14	,	,	,
cord-274307-kl0uvrbw	42	15	rapid	rapid	JJ
cord-274307-kl0uvrbw	42	16	assessment	assessment	NN
cord-274307-kl0uvrbw	42	17	,	,	,
cord-274307-kl0uvrbw	42	18	production	production	NN
cord-274307-kl0uvrbw	42	19	)	)	-RRB-
cord-274307-kl0uvrbw	42	20	become	become	VBP
cord-274307-kl0uvrbw	42	21	a	a	DT
cord-274307-kl0uvrbw	42	22	diplomatic	diplomatic	JJ
cord-274307-kl0uvrbw	42	23	weapon	weapon	NN
cord-274307-kl0uvrbw	42	24	or	or	CC
cord-274307-kl0uvrbw	42	25	even	even	RB
cord-274307-kl0uvrbw	42	26	a	a	DT
cord-274307-kl0uvrbw	42	27	propaganda	propaganda	NN
cord-274307-kl0uvrbw	42	28	tool	tool	NN
cord-274307-kl0uvrbw	42	29	for	for	IN
cord-274307-kl0uvrbw	42	30	external	external	JJ
cord-274307-kl0uvrbw	42	31	or	or	CC
cord-274307-kl0uvrbw	42	32	internal	internal	JJ
cord-274307-kl0uvrbw	42	33	propaganda	propaganda	NN
cord-274307-kl0uvrbw	42	34	?	?	.
cord-274307-kl0uvrbw	43	1	Because	because	IN
cord-274307-kl0uvrbw	43	2	drugs	drug	NNS
cord-274307-kl0uvrbw	43	3	have	have	VBP
cord-274307-kl0uvrbw	43	4	also	also	RB
cord-274307-kl0uvrbw	43	5	become	become	VBN
cord-274307-kl0uvrbw	43	6	a	a	DT
cord-274307-kl0uvrbw	43	7	domestic	domestic	JJ
cord-274307-kl0uvrbw	43	8	political	political	JJ
cord-274307-kl0uvrbw	43	9	issue	issue	NN
cord-274307-kl0uvrbw	43	10	,	,	,
cord-274307-kl0uvrbw	43	11	as	as	IN
cord-274307-kl0uvrbw	43	12	we	-PRON-	PRP
cord-274307-kl0uvrbw	43	13	have	have	VBP
cord-274307-kl0uvrbw	43	14	seen	see	VBN
cord-274307-kl0uvrbw	43	15	with	with	IN
cord-274307-kl0uvrbw	43	16	chloroquine	chloroquine	NN
cord-274307-kl0uvrbw	43	17	and	and	CC
cord-274307-kl0uvrbw	43	18	hydroxychloroquine	hydroxychloroquine	NN
cord-274307-kl0uvrbw	43	19	,	,	,
cord-274307-kl0uvrbw	43	20	with	with	IN
cord-274307-kl0uvrbw	43	21	partisan	partisan	JJ
cord-274307-kl0uvrbw	43	22	confrontations	confrontation	NNS
cord-274307-kl0uvrbw	43	23	or	or	CC
cord-274307-kl0uvrbw	43	24	positions	position	NNS
cord-274307-kl0uvrbw	43	25	taken	take	VBN
cord-274307-kl0uvrbw	43	26	without	without	IN
cord-274307-kl0uvrbw	43	27	scientific	scientific	JJ
cord-274307-kl0uvrbw	43	28	basis	basis	NN
cord-274307-kl0uvrbw	43	29	by	by	IN
cord-274307-kl0uvrbw	43	30	a	a	DT
cord-274307-kl0uvrbw	43	31	head	head	NN
cord-274307-kl0uvrbw	43	32	of	of	IN
cord-274307-kl0uvrbw	43	33	state	state	NN
cord-274307-kl0uvrbw	43	34	announcing	announce	VBG
cord-274307-kl0uvrbw	43	35	his	-PRON-	PRP$
cord-274307-kl0uvrbw	43	36	belief	belief	NN
cord-274307-kl0uvrbw	43	37	in	in	IN
cord-274307-kl0uvrbw	43	38	the	the	DT
cord-274307-kl0uvrbw	43	39	interest	interest	NN
cord-274307-kl0uvrbw	43	40	of	of	IN
cord-274307-kl0uvrbw	43	41	chloroquine	chloroquine	NN
cord-274307-kl0uvrbw	43	42	,	,	,
cord-274307-kl0uvrbw	43	43	in	in	IN
cord-274307-kl0uvrbw	43	44	a	a	DT
cord-274307-kl0uvrbw	43	45	country	country	NN
cord-274307-kl0uvrbw	43	46	that	that	WDT
cord-274307-kl0uvrbw	43	47	was	be	VBD
cord-274307-kl0uvrbw	43	48	the	the	DT
cord-274307-kl0uvrbw	43	49	first	first	JJ
cord-274307-kl0uvrbw	43	50	to	to	TO
cord-274307-kl0uvrbw	43	51	create	create	VB
cord-274307-kl0uvrbw	43	52	a	a	DT
cord-274307-kl0uvrbw	43	53	regulatory	regulatory	JJ
cord-274307-kl0uvrbw	43	54	agency	agency	NN
cord-274307-kl0uvrbw	43	55	.	.	.
cord-274307-kl0uvrbw	44	1	The	the	DT
cord-274307-kl0uvrbw	44	2	balance	balance	NN
cord-274307-kl0uvrbw	44	3	between	between	IN
cord-274307-kl0uvrbw	44	4	political	political	JJ
cord-274307-kl0uvrbw	44	5	power	power	NN
cord-274307-kl0uvrbw	44	6	and	and	CC
cord-274307-kl0uvrbw	44	7	regulatory	regulatory	JJ
cord-274307-kl0uvrbw	44	8	agencies	agency	NNS
cord-274307-kl0uvrbw	44	9	may	may	MD
cord-274307-kl0uvrbw	44	10	be	be	VB
cord-274307-kl0uvrbw	44	11	shifting	shift	VBG
cord-274307-kl0uvrbw	44	12	,	,	,
cord-274307-kl0uvrbw	44	13	as	as	IN
cord-274307-kl0uvrbw	44	14	shown	show	VBN
cord-274307-kl0uvrbw	44	15	by	by	IN
cord-274307-kl0uvrbw	44	16	the	the	DT
cord-274307-kl0uvrbw	44	17	announcement	announcement	NN
cord-274307-kl0uvrbw	44	18	by	by	IN
cord-274307-kl0uvrbw	44	19	the	the	DT
cord-274307-kl0uvrbw	44	20	President	President	NNP
cord-274307-kl0uvrbw	44	21	of	of	IN
cord-274307-kl0uvrbw	44	22	the	the	DT
cord-274307-kl0uvrbw	44	23	United	United	NNP
cord-274307-kl0uvrbw	44	24	States	States	NNP
cord-274307-kl0uvrbw	44	25	of	of	IN
cord-274307-kl0uvrbw	44	26	America	America	NNP
cord-274307-kl0uvrbw	44	27	,	,	,
cord-274307-kl0uvrbw	44	28	in	in	IN
cord-274307-kl0uvrbw	44	29	person	person	NN
cord-274307-kl0uvrbw	44	30	,	,	,
cord-274307-kl0uvrbw	44	31	of	of	IN
cord-274307-kl0uvrbw	44	32	the	the	DT
cord-274307-kl0uvrbw	44	33	authorisation	authorisation	NN
cord-274307-kl0uvrbw	44	34	of	of	IN
cord-274307-kl0uvrbw	44	35	an	an	DT
cord-274307-kl0uvrbw	44	36	antiviral	antiviral	JJ
cord-274307-kl0uvrbw	44	37	by	by	IN
cord-274307-kl0uvrbw	44	38	the	the	DT
cord-274307-kl0uvrbw	44	39	FDA	FDA	NNP
cord-274307-kl0uvrbw	44	40	,	,	,
cord-274307-kl0uvrbw	44	41	developed	develop	VBN
cord-274307-kl0uvrbw	44	42	by	by	IN
cord-274307-kl0uvrbw	44	43	an	an	DT
cord-274307-kl0uvrbw	44	44	American	american	JJ
cord-274307-kl0uvrbw	44	45	company	company	NN
cord-274307-kl0uvrbw	44	46	,	,	,
cord-274307-kl0uvrbw	44	47	even	even	RB
cord-274307-kl0uvrbw	44	48	though	though	IN
cord-274307-kl0uvrbw	44	49	the	the	DT
cord-274307-kl0uvrbw	44	50	results	result	NNS
cord-274307-kl0uvrbw	44	51	of	of	IN
cord-274307-kl0uvrbw	44	52	clinical	clinical	JJ
cord-274307-kl0uvrbw	44	53	trials	trial	NNS
cord-274307-kl0uvrbw	44	54	are	be	VBP
cord-274307-kl0uvrbw	44	55	still	still	RB
cord-274307-kl0uvrbw	44	56	contradictory	contradictory	JJ
cord-274307-kl0uvrbw	44	57	.	.	.
cord-274307-kl0uvrbw	45	1	It	-PRON-	PRP
cord-274307-kl0uvrbw	45	2	is	be	VBZ
cord-274307-kl0uvrbw	45	3	the	the	DT
cord-274307-kl0uvrbw	45	4	same	same	JJ
cord-274307-kl0uvrbw	45	5	with	with	IN
cord-274307-kl0uvrbw	45	6	a	a	DT
cord-274307-kl0uvrbw	45	7	nationalist	nationalist	JJ
cord-274307-kl0uvrbw	45	8	attitude	attitude	NN
cord-274307-kl0uvrbw	45	9	for	for	IN
cord-274307-kl0uvrbw	45	10	the	the	DT
cord-274307-kl0uvrbw	45	11	priority	priority	NN
cord-274307-kl0uvrbw	45	12	delivery	delivery	NN
cord-274307-kl0uvrbw	45	13	of	of	IN
cord-274307-kl0uvrbw	45	14	vaccine	vaccine	NN
cord-274307-kl0uvrbw	45	15	.	.	.
cord-274307-kl0uvrbw	46	1	Will	Will	MD
cord-274307-kl0uvrbw	46	2	drug	drug	NN
cord-274307-kl0uvrbw	46	3	policy	policy	NN
cord-274307-kl0uvrbw	46	4	tomorrow	tomorrow	NN
cord-274307-kl0uvrbw	46	5	become	become	VBP
cord-274307-kl0uvrbw	46	6	a	a	DT
cord-274307-kl0uvrbw	46	7	subject	subject	NN
cord-274307-kl0uvrbw	46	8	of	of	IN
cord-274307-kl0uvrbw	46	9	electoral	electoral	JJ
cord-274307-kl0uvrbw	46	10	debate	debate	NN
cord-274307-kl0uvrbw	46	11	,	,	,
cord-274307-kl0uvrbw	46	12	on	on	IN
cord-274307-kl0uvrbw	46	13	a	a	DT
cord-274307-kl0uvrbw	46	14	par	par	NN
cord-274307-kl0uvrbw	46	15	with	with	IN
cord-274307-kl0uvrbw	46	16	fiscal	fiscal	JJ
cord-274307-kl0uvrbw	46	17	or	or	CC
cord-274307-kl0uvrbw	46	18	educational	educational	JJ
cord-274307-kl0uvrbw	46	19	policy	policy	NN
cord-274307-kl0uvrbw	46	20	,	,	,
cord-274307-kl0uvrbw	46	21	and	and	CC
cord-274307-kl0uvrbw	46	22	an	an	DT
cord-274307-kl0uvrbw	46	23	argument	argument	NN
cord-274307-kl0uvrbw	46	24	for	for	IN
cord-274307-kl0uvrbw	46	25	economic	economic	JJ
cord-274307-kl0uvrbw	46	26	nationalism	nationalism	NN
cord-274307-kl0uvrbw	46	27	?	?	.
cord-274307-kl0uvrbw	47	1	How	how	WRB
cord-274307-kl0uvrbw	47	2	can	can	MD
cord-274307-kl0uvrbw	47	3	we	-PRON-	PRP
cord-274307-kl0uvrbw	47	4	reconcile	reconcile	VB
cord-274307-kl0uvrbw	47	5	this	this	DT
cord-274307-kl0uvrbw	47	6	irruption	irruption	NN
cord-274307-kl0uvrbw	47	7	in	in	IN
cord-274307-kl0uvrbw	47	8	the	the	DT
cord-274307-kl0uvrbw	47	9	public	public	JJ
cord-274307-kl0uvrbw	47	10	or	or	CC
cord-274307-kl0uvrbw	47	11	political	political	JJ
cord-274307-kl0uvrbw	47	12	debate	debate	NN
cord-274307-kl0uvrbw	47	13	and	and	CC
cord-274307-kl0uvrbw	47	14	the	the	DT
cord-274307-kl0uvrbw	47	15	maintenance	maintenance	NN
cord-274307-kl0uvrbw	47	16	of	of	IN
cord-274307-kl0uvrbw	47	17	a	a	DT
cord-274307-kl0uvrbw	47	18	sufficient	sufficient	JJ
cord-274307-kl0uvrbw	47	19	level	level	NN
cord-274307-kl0uvrbw	47	20	of	of	IN
cord-274307-kl0uvrbw	47	21	expertise	expertise	NN
cord-274307-kl0uvrbw	47	22	to	to	TO
cord-274307-kl0uvrbw	47	23	avoid	avoid	VB
cord-274307-kl0uvrbw	47	24	falling	fall	VBG
cord-274307-kl0uvrbw	47	25	into	into	IN
cord-274307-kl0uvrbw	47	26	the	the	DT
cord-274307-kl0uvrbw	47	27	populism	populism	NN
cord-274307-kl0uvrbw	47	28	we	-PRON-	PRP
cord-274307-kl0uvrbw	47	29	know	know	VBP
cord-274307-kl0uvrbw	47	30	in	in	IN
cord-274307-kl0uvrbw	47	31	other	other	JJ
cord-274307-kl0uvrbw	47	32	fields	field	NNS
cord-274307-kl0uvrbw	47	33	,	,	,
cord-274307-kl0uvrbw	47	34	with	with	IN
cord-274307-kl0uvrbw	47	35	its	-PRON-	PRP$
cord-274307-kl0uvrbw	47	36	share	share	NN
cord-274307-kl0uvrbw	47	37	of	of	IN
cord-274307-kl0uvrbw	47	38	false	false	JJ
cord-274307-kl0uvrbw	47	39	or	or	CC
cord-274307-kl0uvrbw	47	40	truncated	truncated	JJ
cord-274307-kl0uvrbw	47	41	information	information	NN
cord-274307-kl0uvrbw	47	42	?	?	.
cord-274307-kl0uvrbw	48	1	the	the	DT
cord-274307-kl0uvrbw	48	2	participants	participant	NNS
cord-274307-kl0uvrbw	48	3	of	of	IN
cord-274307-kl0uvrbw	48	4	Giens	Giens	NNP
cord-274307-kl0uvrbw	48	5	XXXV	XXXV	NNP
cord-274307-kl0uvrbw	48	6	Round	Round	NNP
cord-274307-kl0uvrbw	48	7	Table	Table	NNP
cord-274307-kl0uvrbw	48	8	Clinical	Clinical	NNP
cord-274307-kl0uvrbw	48	9	Research	Research	NNP
cord-274307-kl0uvrbw	48	10	.	.	.
cord-274307-kl0uvrbw	49	1	From	from	IN
cord-274307-kl0uvrbw	49	2	single	single	JJ
cord-274307-kl0uvrbw	49	3	-	-	HYPH
cord-274307-kl0uvrbw	49	4	arm	arm	NN
cord-274307-kl0uvrbw	49	5	studies	study	NNS
cord-274307-kl0uvrbw	49	6	to	to	TO
cord-274307-kl0uvrbw	49	7	externally	externally	RB
cord-274307-kl0uvrbw	49	8	controlled	control	VBN
cord-274307-kl0uvrbw	49	9	studies	study	NNS
cord-274307-kl0uvrbw	49	10	.	.	.
cord-274307-kl0uvrbw	50	1	Methodological	methodological	JJ
cord-274307-kl0uvrbw	50	2	considerations	consideration	NNS
cord-274307-kl0uvrbw	50	3	and	and	CC
cord-274307-kl0uvrbw	50	4	guidelines	guideline	NNS
cord-274307-kl0uvrbw	51	1	Quelle	Quelle	NNP
cord-274307-kl0uvrbw	51	2	utilisation	utilisation	NN
cord-274307-kl0uvrbw	51	3	et	et	FW
cord-274307-kl0uvrbw	51	4	quelle	quelle	FW
cord-274307-kl0uvrbw	51	5	hiérarchisation	hiérarchisation	NN
cord-274307-kl0uvrbw	51	6	pour	pour	FW
cord-274307-kl0uvrbw	51	7	les	les	FW
cord-274307-kl0uvrbw	51	8	critères	critères	FW
cord-274307-kl0uvrbw	51	9	de	de	FW
cord-274307-kl0uvrbw	51	10	jugement	jugement	NNP
cord-274307-kl0uvrbw	51	11	secondaires	secondaires	NNPS
cord-274307-kl0uvrbw	51	12	Social	Social	NNP
cord-274307-kl0uvrbw	51	13	pharmacology	pharmacology	NN
cord-274307-kl0uvrbw	51	14	:	:	:
cord-274307-kl0uvrbw	52	1	a	a	DT
cord-274307-kl0uvrbw	52	2	new	new	JJ
cord-274307-kl0uvrbw	52	3	topic	topic	NN
cord-274307-kl0uvrbw	52	4	in	in	IN
cord-274307-kl0uvrbw	52	5	clinical	clinical	JJ
cord-274307-kl0uvrbw	52	6	pharmacology	pharmacology	NN
cord-274307-kl0uvrbw	52	7	Pharmacovid	Pharmacovid	NNP
cord-274307-kl0uvrbw	52	8	plateform	plateform	NN
cord-274307-kl0uvrbw	52	9	:	:	:
cord-274307-kl0uvrbw	52	10	questions	question	NNS
cord-274307-kl0uvrbw	52	11	and	and	CC
cord-274307-kl0uvrbw	52	12	answers	answer	NNS
cord-274307-kl0uvrbw	52	13	for	for	IN
cord-274307-kl0uvrbw	52	14	the	the	DT
cord-274307-kl0uvrbw	52	15	public	public	NN
cord-274307-kl0uvrbw	52	16	about	about	IN
cord-274307-kl0uvrbw	52	17	drugs	drug	NNS
cord-274307-kl0uvrbw	52	18	in	in	IN
cord-274307-kl0uvrbw	52	19	the	the	DT
cord-274307-kl0uvrbw	52	20	context	context	NN
cord-274307-kl0uvrbw	52	21	of	of	IN
cord-274307-kl0uvrbw	52	22	the	the	DT
cord-274307-kl0uvrbw	52	23	COVID-19	covid-19	NN